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1Abstract
The aim of this study was to investigate a sixty cow dairy herd with a persistently high 
bulk milk somatic cell count (BMSCC) and to find ways to control the problem.
Investigations were initiated in November 1996 following notification to the farmer by 
the milk purchaser of possible termination of the milk contract if the BMSCC were not reduced 
to an acceptable level. The BMSCC had been greater than the EC standard of 400,000 cells/ml 
of milk since the winter of 1995. Investigation of the high BMSCC began by assessing the 
milking routine and by the measuring individual cow somatic cell counts (ICSCC). Cows were 
subsequently selected for California Mastitis Testing (CMT) on the basis of ICSCC > 400,000 
cells/ml. Individual quarter samples, positive on CMT, were submitted for bacteriological 
culture. The results showed 67% of cows sampled to have infection with Streptococcus 
agalactiae and 43% to have infection with Staphylococcus aureus. The milking routine and 
general management on the farm were poor. Improvements in record keeping, general 
management and strict adherence to the mastitis control programme termed the ‘Five Point 
Plan’ were advised. Following uptake of these recommendations, whole herd ‘blitz therapy’ 
was implemented. The aim of the chosen treatment was to eliminate Streptococcus agalactiae 
infection from the herd and to produce a rapid reduction in the BMSCC, thereby allowing the 
farmer to continue to market the milk. The ‘blitz therapy’ comprised of intramammary 
treatment, with nafcillin, dihydrostreptomycin and benzyl penicillin (Nafpenzal MC; Intervet 
UK Limited), and parenteral treatment with penicillin (Depocillin; Intervet UK Limited), of all 
lactating cows; and parenteral treatment with amoxycillin and clavulanic acid (Synulox Ready- 
To-Use Injection; Pfizer Limited), of the dry cows and maiden heifers. The milk was discarded 
for the longest recommended withdrawal period for the drugs used and the milk purchaser 
tested the milk for antibiotic residues prior to collection for commercial sale.
In order to assess the response to the management changes and to the whole herd ‘blitz 
therapy’, weekly BMSCC were monitored and bulk milk samples were collected for 
bacteriological culture weekly for 12 weeks, and then monthly for the next 9 months. In 
addition, bacteriological culture of individual quarter samples from all the lactating cows in the 
herd was carried out on two occasions following the ‘blitz therapy’, and from selected cows on 
two later occasions and from cows which calved within one month of the ‘blitz therapy’. 
Individual quarter somatic cell counts (IQSCC) were carried out on the cows sampled during 
the herd screenings and were mostly within acceptable limits, i.e. < 250,000 cells/ml. The 
BMSCC was reduced to below 400,000 cells/ml for at least one year after the ‘blitz therapy’. 
Streptococcus agalactiae was not isolated from any of the bulk milk samples or from any of the 
cows, with the exception of one cow which had been dry at the time of the herd treatment. This 
cow was isolated immediately and treated. Repeated sampling from this cow failed to detect 
Streptococcus agalactiae infection and to date, the herd has remained free of Streptococcus 
agalactiae infection for one year.
The isolation of Staphylococcus aureus from 10/22 weekly or monthly bulk tank 
samples and also from 28% of the cows on one, or more, occasions during the herd screenings 
led to an attempt to reduce Staphylococcus aureus infection in the herd. Six cows from which 
Staphylococcus aureus was isolated from one or more milk samples taken during the herd 
screenings, were selected for antibiotic treatment. Ceftiofur (Excenel Sterile Powder; 
Pharmacia and Upjohn Limited) was administered parenterally to these cows once a day for 10 
days. Following treatment, monitoring showed that despite the fact that fewer colonies of 
Staphylococcus aureus were cultured the bacteria were still present in the milk of these cows, 
indicating that this treatment failed to eradicate Staphylococcus aureus.
In conclusion, despite failing to eliminate Staphylococcus aureus from treated cows, 
the combined effects of improved management and ‘blitz therapy’ were successful in bringing 
about a dramatic reduction in BMSCC, eliminating Streptococcus agalactiae and ensuring the 
farmer was able to market the milk. The reduction in the level of mastitis in this herd has 
meant greater financial returns for the farmer through increased yield and reduced penalties, in 
addition to a great improvement in cowVfelfare on this farm.
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Chapter 1 
Introduction
1.1. Mastitis
1.1.1. The disease
Mastitis is defined as inflammation of the mammary gland and is characterised by 
physical and chemical changes in the milk, expressed, among other things, by an 
increased number of somatic cells (Tolle, 1975). Milk somatic cells consist of white 
blood cells (O’Rourke and Blowey, 1992; Hillerton, 1997) and epithelial cells 
(Hillerton, 1997). Somatic cell counts (SCC) provide a good estimate of the degree 
of inflammation present in the udder at the time o f sampling (Sears and others, 1993; 
Logue, 1997). White blood cells enter the milk from the blood in response to 
inflammation and epithelial cells are shed from the lining of the udder tissue (Philpot, 
1984; Nickerson, 1985; Blowey and Edmondson, 1995). The entry of mastitis 
pathogens into the udder induces a massive influx o f white blood cells in an attempt 
to eliminate the bacteria (Sandholm and others, 1990). If the infection is successfully 
eliminated, the cell count returns to normal, but if  the white cell response is 
unsuccessful, subclinical infection becomes established and there will be a continued 
secretion of white blood cells into the milk resulting in an increased SCC (Blowey 
and Edmondson, 1995). Milk from normal, uninfected glands usually has a SCC 
which is less than 100,000 cells/ml, whereas the average SCC for glands with 
subclinical infection can increase to 500,000-1 million cells/ml, and for clinical 
Staphyloccus aureus infections the SCC can be approximately 4 million cells/ml and 
for clinical Sterptoccus uberis or coliform infections the SCC can be approximately 
20 million cells/ml (Hillerton, 1997).
All herds are susceptible to mastitis (Wilson and Kingwill, 1975). Mastitis is caused 
by pathogenic micro-organisms, usually bacteria (Wilson and Richards, 1980; 
Sandholm and others, 1990; Watts, 1990; Sears and others, 1993; Cullor and Tyler,
12
1996), although the organism may not be present at the time of examination (Sears 
and others, 1993). Mastitis is a complex disease syndrome, and for convenience is 
often classified as either contagious mastitis or environmental mastitis (Rebhun, 
1995). Contagious mastitis is caused by organisms that can colonise the mammary 
gland and can be spread by the milking procedure, contaminated machinery (Tolle, 
1975; Cullor and Tyler, 1996; Logan and Gillespie, 1996), the hands o f milkers 
(Tolle, 1975; Fox and Gay, 1993; Rebhun, 1995; Cullor and Tyler, 1996; Smith and 
Hogan, 1996) and nursing calves (Cullor and Tyler, 1996). Environmental mastitis is 
caused by environmental pathogens that do not normally infect the mammary gland, 
but can do so when contamination of the cow’s environment, teats, udder or milking 
machine occurs and the organisms gain access to the teat cistern (Rebhun, 1995). A 
dramatic reduction in the prevalence o f contagious pathogens and an associated 
reduction in bulk milk somatic cell counts (BMSCC) has been seen over the last 30 
years (Booth, 1993; Smith and Hogan, 1996). Booth (1985) showed that over a 13 
year period, in herds in the UK, a 32% reduction in the average BMSCC was seen, a 
reduction from 573,000 cells/ml to 310,000 cells/ml.
Mastitis may also be classified as subclinical, where the mammary gland and milk 
appear normal, or clinical, which is characterised by inflammatory changes in the 
mammary gland and alteration in the appearance of the milk (Philpot, 1984).
1.1.2. Clinical mastitis
Clinical mastitis can be further classified as peracute, acute, subacute or chronic 
(Tolle, 1975; Radostits and others, 1994a; Cullor and Tyler, 1996), and is 
characterised by grossly abnormal milk with varying degrees of mammary gland 
inflammation (Sears and others, 1993; Cullor and Tyler, 1996). Signs of 
inflammation include redness, heat, swelling and pain (Blowey, 1990; Cullor and 
Tyler, 1996) and loss of function of the mammary gland (O’Rourke and Blowey,
1992). When there is severe inflammation with swelling, heat and pain of the quarter 
and there is a marked systemic reaction mastitis is classified as peracute; when there 
is severe inflammation but little or no systemic reaction it is classified as acute; when 
there is mild inflammation with persistently abnormal secretion o f the udder it is
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classified as subacute; and when there is recurrent bouts of inflammation with little 
change in the milk it is classified as chronic (Jain, 1979; Radostits and others, 
1994a). In peracute mastitis, the clinical signs can be varied, but are usually severe 
with a sudden onset. The clinical signs can include depression, anorexia, pyrexia and 
recumbency (Bramley, 1992; Cullor and Tyler, 1996). The systemic signs are often 
detected before the local inflammation is noticed (Bramley, 1992).
Over a 12 month period Blowey (1984) found the mean incidence o f clinical mastitis 
to be 26.5% of cattle in UK dairy herds: 51 cases occurred per 100 cows suggesting 
that cows getting mastitis were likely to get clinical mastitis twice in 12 months. 
Similar rates of mastitis infection were shown in data provided by Kossaibati and 
Esslemont (1995) in the University of Reading Daisy Report, who found a mean of 
33.2 cases o f clinical mastitis per 100 cows with 21% of the herd affected with 1.6 
cases per affected cow per year.
1.1.3. Subclinical mastitis
Subclinical mastitis occurs when the mammary gland is infected and the number of 
leucocytes (somatic cells) is increased, but the milk appears to be grossly normal and 
there is no clinically detectable sign of inflammation in the mammary gland (Sears 
and others, 1993; Cullor and Tyler, 1996). Mastitis is most often subclinical 
(Radostits and others, 1994a) and indeed subclinical mastitis was reported by 
Newbould (1984) to account for 70% of all infected quarters. According to Biggs
(1996), an individual cow somatic cell count (ICSCC) of > 200,000 cells/ml can be 
taken to indicate subclinical infection. Over time, repeated or persistent bouts of 
subclinical mastitis will lead to fibrosis o f mammary tissue producing firmer glands 
and a reduction in milk production (Cullor and Tyler, 1996). Contagious pathogens 
are more likely to produce subclinical infections, and hence high SCC, than 
environmental pathogens (Eberhart and others, 1982; Blowey and Edmondson,
1995). This is due to the rapid elimination of environmental organisms in cases of 
environmental mastitis, when high SCC usually occur only during the period of 
clinical mastitis (Blowey and Edmondson, 1995). However, it should be 
remembered that chronically infected glands can have low SCC because o f the cyclic
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shedding of organisms (Sears and others, 1993; Lawrence, 1997). The main cause of 
high BMSCC in Scottish dairy herds was found to be subclinical infection with 
Streptococcus agalactiae infection, which was found in 83% of the herds sampled, 
this was assessed from individual cow or quarter sampling (Logue, 1997). 
Staphylococcus aureus infection was found to be the most prevalent pathogen in 
herds where the BMSCC remained above 400,000 cells/ml for at least one year after 
the first sampling (Logue, 1997). The average reduction in milk output per quarter 
per lactation resulting from mastitis has been reported to be 15-40% depending on 
the type, severity and duration o f infection (Hale and others, 1956; Beck and others,
1992).
1.2. Economics
Mastitis is a major disease problem for the dairy industry (Booth, 1988; Sischo and 
others, 1990; Bramley, 1992; O ’Rourke and Blowey, 1992; Smith and Hogan, 1993; 
Muldoon, 1995), causing significant economic losses (Wilson and Kingwill, 1975; 
Esslemont and Peeler, 1993; Rebhun, 1995). Mastitis is reported to be the most 
costly disease of dairy cattle (Roberts and others, 1969; Schmidt, 1969; Watts, 1990; 
De Graves and Fetrow, 1993). It is quoted as being the most common disease of 
dairy cattle contributing to culling and is responsible for 10% of premature disposals 
(Esslemont and Spincer, 1993). Economic losses associated with mastitis are due to 
loss of production, the cost o f treatment and prevention (De Graves and Fetrow, 
1993; Reneau, 1993; Radostits and others, 1994b), discarded milk, early culling, drug 
costs, veterinary expenses, increased labour (De Graves and Fetrow, 1993; Reneau,
1993) and reduced milk yields (Janzen, 1970; Nickerson, 1985).
The greatest loss caused by clinical mastitis is the loss in milk production, this 
involves the reduction in milk yield and the discarding of milk due to the use of 
antibiotics (Kossaibati and Esslemont, 1995). Subclinical infections will also 
decrease the milk yield and alter the composition of the milk (Bramley, 1992; 
Harmon, 1994). Herds with high BMSCC give lower milk yields than herds with 
lower BMSCC (Bramley and Dodd, 1984). The lactation milk yield of the average
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cow is reduced by 77 kg (77 litres) for every increase of 100,000 somatic cells/ml in 
the annual mean BMSCC of the herd (Booth, 1981). Winkler (1982) reports a 3% 
reduction in lactation milk yield with BMSCC 150,000 - 225,000 cells/ml, a 5% 
reduction with BMSCC 260,000-380,000 cells/ml, 8-12% reduction with BMSCC 
420,000-1.2 million cells/ml and 16-20 % reduction in milk production with BMSCC 
1.28-2.28 million cells/ml. Studies in Canada demonstrated that milk yields can drop 
by 2.5% for every 100,000 increase in SCC above the baseline o f 200,000 cells/ml 
(Philpot, 1984). Seventy five percent of losses from subclinical mastitis are 
accounted for by reduced production (Fetrow, 1980; Philpot, 1984). Unfortunately, 
75% of the subclinical losses are ‘invisible’ to the dairy manager, whereas the costs 
of treatment, control and prevention are highly ‘visible’ (Fetrow, 1980). Booth 
(1981) calculated, from 1980 milk prices, that an annual loss of approximately £87 
million was due to reduced milk sales alone i.e. £27 for every dairy cow in the UK at 
that time. Kossaibati and Esslemont (1995) recorded the average direct cost o f a case 
of mastitis as £119. The direct costs involved in cases o f mastitis can vary from £80 
for a mild case, £208 for a severe case and £200 for a fatal case: including the 
replacement of the cow the cost can be as much as £2,214.
1.3. Legislation
Consumer pressure and demands by international markets for high quality dairy 
products drive milk producers to strive for further improvements in mastitis control 
(Reneau, 1993; Smith and Hogan, 1996). The European Community Health and 
Hygiene Directive 92/46, detailing standards for the hygienic quality o f milk 
intended for human consumption, has had major implications for the dairy industry. 
The EC directive requires bulk milk to have a total bacteria count (TBC) < 100,000 
bacteria/ml and SCC < 400,000 cells/ml. In addition to reducing SCC, pressure 
exists to reduce the incidence o f clinical cases o f mastitis, to produce milk free of 
antibiotics, other chemical residues and potential human pathogens (Smith and 
Hogan, 1993). In order to avoid exceeding the standard for SCC at some time in the 
year, the recommended target for the annual mean BMSCC should be < 250,000 
cells/ml (Logue and others, 1994).
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Together with the market pressure, the economics of milk production are responsible 
for the current interest in reducing mastitis in dairy herds. The EC directive for lower 
SCC has had a major impact on the UK dairy industry: in March 1991 one fifth of 
UK producers would have failed to meet the SCC standards. The TBC standard had 
far less impact, in March 1991 fewer than one producer in a thousand would have 
failed to meet the standard and even then the failure was only temporary (Logue and 
others, 1994; Logue, 1997). Now, in 1998, all farmers must meet the standards or 
face being unable to sell their milk.
1.4. Epidemiology
1.4.1. General
Susceptibility to intramammary infection, and the rate and duration of infection 
varies widely among dairy herds, and among cows within herds (Philpot, 1975). 
Mastitis occurs more commonly in older cows and in the early lactation period 
(Jackson and Bramley, 1983; Bramley, 1992: Radostits and others, 1994a). The 
higher incidence o f mastitis around calving is due to the rate of new infections gained 
during the dry period, and is thought to be due to suppression of the host defences at 
that time (Bramley, 1992). The increasing ease of penetration of the teat duct by 
pathogens is thought to explain the higher incidence o f mastitis with increasing age 
(Bramley, 1992). Genetic factors such as milk yield, quarter position, length o f teats 
and the milkablity or milking speed o f the cow also have an affect on the 
susceptibility to mastitis (Stovlbaek-Pederson, 1975; Tolle, 1975: Radostits and 
others, 1994a). Teat lesions, particularly at the apex, contribute to an increased 
incidence of intramammary infection (Philpot, 1975; Sandholm and others, 1990; 
Radostits and others, 1994a). Tolle (1975) found that, in the absence of teat dipping, 
all teat lesions became secondarily infected and acted as reservoirs for mastitis 
pathogens. Environmental factors which reduce the udder’s resistance to infection, 
increase the transmission of bacteria from the surroundings and from infected cows 
to healthy cows, and increase the possibility of bacteria penetrating the teat canal, 
will lead to increased incidence o f mastitis (Stovlbaek-Pederson, 1975).
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1.4.2. Somatic cell counting
Somatic cell counting is a practical and effective method to evaluate a herds mastitis 
status and gives a good indication of the amount o f infection in a herd (Booth, 1985; 
Dohoo and Meek, 1982; Sears and others, 1993; Cullor and Tyler, 1996). 
Intramammary infection is the most important factor influencing the number of 
somatic cells in milk (Reneau, 1986). Other factors which influence the somatic cell 
count include breed, age, stage of lactation and physiological stresses such as 
excitement and high temperatures and trauma (Reichmuth, 1975; Tolle, 1975; 
Philpot, 1984; Rebhun, 1995). The variation in SCC observed among different 
breeds may reflect the differing management systems they typically experience 
(Reichmuth, 1975; Radostits and others, 1994a). The SCC tends to increase with the 
age of dairy cows, which may be related to the increased period of exposure to 
potential pathogens, teat canal damage and poorer immune responses (Reichmuth, 
1975; Blowey and Edmondson, 1995). However, in cows older than seven years of 
age, the average SCC is reduced, but this is probably due to the retention o f cows 
with low cell counts, whereas high cell count cows are often selected for early culling 
(Reichmuth, 1975).
There is a rise in somatic cell count between the first and third days o f lactation 
(Cullen, 1968; Reichmuth, 1975; Philpot, 1984; Blowey and Edmondson, 1995; 
Rebhun, 1995), and throughout lactation there tends to be a rise in SCC due to the 
presence of infection (Reichmuth, 1975). There is also a regular cyclical rise and fall 
in SCC during lactation which is probably due to desquamation o f epithelial cells or 
increased alveolar permeability allowing more cellular exudate to be released 
(Cullen, 1968). The increase in SCC towards the end of lactation is exaggerated by 
the reduction in the volume o f milk secreted as lactation advances (Reichmuth, 1975; 
Blowey and Edmondson, 1995; Rebhun, 1995). Stressors can exacerbate the 
inflammatory response which is already present in an irritated udder (Reichmuth, 
1975). Stress related increases in SCC may be caused by errors in feeding methods, 
oestrus and irregular milking intervals (Reichmuth, 1975). Short milking intervals 
tend to be associated with higher SCC because longer intervals allow more secretion
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to be produced thereby diluting the number o f somatic cells in the milk: the so-called 
dilution effect (O’Rourke and Blowey, 1992). BMSCC is regarded as a measure of 
the prevalence of infection in a herd and has been used as a measure of bulk milk 
quality such that payment schemes have been devised to penalise high BMSCC herds 
(Westgarth, 1975; Booth, 1996; Logue, 1997). Financial penalties for high BMSCC 
act as an incentive for farmers to control mastitis and are a useful means to assess 
progress of control programmes (Booth, 1981).
Somatic cell counting can be done at the quarter level when individual milk samples 
are collected from each quarter i.e. individual quarter somatic cell count (IQSCC), or 
at the cow level, when a composite sample of equal volumes o f milk is collected 
from all quarters o f the cow into one container i.e. individual cow somatic cell count 
(ICSCC), or at the bulk tank level i.e. bulk milk somatic cell count (BMSCC).
1.5. Contagious pathogens
Contagious organisms associated with mastitis include Staphylococcus aureus, 
Streptococcus agalactiae, Streptococcus dysgalactiae (Natzke, 1981; Dodd, 1983; 
Smith, 1983) and Mycoplasma spp. (Rebhun, 1995). Subclinical mastitis is most 
commonly associated with S. aureus and S. agalactiae infections (Sears and others, 
1993; Cullor and Tyler, 1996). Streptococcus agalactiae and/or S. aureus have been 
shown to be responsible for 85-95% of bovine mastitis cases (Wilson and Kingwill, 
1975; Natzke, 1981; Dodd, 1983; Mercer and Sears, 1983) and have frequently been 
found to infect more than one quarter of the same cow (Logue, 1997). Gunn (1995) 
found, in studies of Scottish dairy herds, that S. agalactiae and S. aureus were the 
most prevalent mastitis pathogens in high BMSCC herds.
1.5.1. Staphylococcus aureus
Staphylococcus aureus is a contagious pathogen which can be found on the skin of 
the udder and teats as well as in intramammary tissue (McDonald, 1977; Cullor and 
Tyler, 1996). There are many different strains o f S. aureus which can cause mastitis
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and they have been demonstrated using restriction enzyme fragmentation patterns 
(Young, 1997). Most S. aureus infections are chronic subclinical infections, though 
occasional clinical cases occur which are mostly mild to moderate in severity (Cullor 
and Tyler, 1996). These intramammary infections tend to be o f a long duration 
(Bramley and Dodd, 1984). Occasionally, an acute gangrenous toxic mastitis can 
result from S. aureus infection (Bramley, 1992). Acute gangrenous mastitis is 
recognised initially as a hot, red, swollen gland which rapidly becomes cold and the 
secretion becomes sero-sanguinous (Radostits and others, 1994a; Cullor and Tyler,
1996). If untreated, the gland becomes discoloured, and this area then sloughs within 
10-14 days (Radostits and others, 1994a; Cullor and Tyler, 1996). Affected cows are 
dehydrated, depressed, anorexic, pyrexic and exhibit signs of toxaemia (Radostits 
and others, 1994a; Cullor and Tyler, 1996). Fortunately, gangrenous mastitis is not 
common (Cullor and Tyler, 1996).
In a study of Scottish dairy herds by Logue (1997), S. aureus was the most common 
cause of both subclinical and clinical mastitis from samples sent to veterinary 
investigation centres. Staphylococcus aureus is difficult to eliminate as it can 
survive for extended periods on the skin (McDonald, 1977) and can survive within 
neutrophils, which serves to protect it from antibiotics (Craven and Anderson, 1979; 
Sandholm and others, 1990). Important sources o f S. aureus infection within the 
dairy herd are infected mammary glands (Davidson, 1961) and infected teat lesions 
(Francis, 1980; Bramley, 1992). Intensive intramammary therapy is often 
unsuccessful in eliminating infection with S. aureus and culling may be necessary 
(McDonald, 1977). Antibiotic treatment o f S. aureus is reported to result in a poor 
success rate and is considered to be a major limitation in the effectiveness of mastitis 
therapy (Bramley and Dodd, 1984). The exception to this rule is clinical 
staphylococcal infections where the clinical response to therapy is good i.e. reduction 
in SCC and resolution o f clinical signs o f mastitis, though less than 35% of the 
infections are eliminated. The reasons for poor clearance o f staphylococcal 
infections may be due to resultant mammary abscessation, the intracellular position 
of bacteria within neutrophils (Madgwick and others, 1989) and antibiotic resistance 
due to p-lactamase production and virulence factors (Sandholm and others, 1990;
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Fox and Gay, 1993). p-lactamase is produced by S. aureus and renders the P-lactam 
ring in penicillins inactive (Sandholm and others, 1990; McKellar, 1991; Vestweber 
and Leipold, 1993).
1.5.2. Streptococcus agalactiae
Streptococcus agalactiae is a highly contagious obligate pathogen of the bovine 
mammary gland (McDonald, 1977; Biggs, 1996; Cullor and Tyler, 1996). Logue
(1997) reported that S. agalactiae was the second most common isolate in herds 
tested, but was not commonly a cause o f clinical cases o f mastitis. The primary site 
o f colonisation in infection is udder tissue, but teat lesions and teat ducts can 
frequently be colonised (Dodd, 1983). Streptococcus agalactiae dies when exposed 
on healthy or eroded skin, is sensitive to penicillin (Plommet and LeLouedee, 1975), 
and can be eradicated from herds (Philpot, 1975; McDonald, 1977). Infection is 
almost always introduced into a herd by purchased cattle (Roberts and others, 1969; 
Biggs, 1996). In S. agalactiae infection, there is often only one quarter infected, but 
it is possible for the other quarters to become infected, especially in herds where the 
infection is endemic (Biggs, 1996). Infected cows have increased somatic cell counts 
at all stages of subclinical infection (Blowey and Edmondson, 1995) and the milk 
yield can be reduced by approximately 10% (Hale and others, 1956). However, both 
the ICSCC and the excretion of bacteria in milk can vary considerably (Blowey and 
Edmondson, 1995). If the BMSCC has been increased for a number of years in a 
herd where S. agalactiae has been isolated, then the infection is likely to be endemic 
(Biggs, 1996). In this situation, ICSCC for some cows in the herd could be in the 
region of 1,000,000-2,000,000 cells/ml could be expected (Biggs, 1996). In herds 
where S. agalactiae infection is responsible for BMSCC > 500,000 cells/ml, 
organisms can be readily isolated from the bulk milk samples (Blowey and 
Edmondson, 1995). Streptococcus agalactiae is the only mastitis pathogen likely to 
respond well to treatment during lactation (Philpot, 1984). The incidence o f S. 
agalactiae infection is reduced significantly by adopting good milking hygiene 
practices and good milking technique (Philpot, 1975).
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1.6. Diagnosis
Diagnostic tests are used to identify the nature and extent of a mastitis problem in a 
dairy herd or to identify an individual animal for segregation, treatment or culling 
(Bramley, 1992). Somatic cell counting is used to diagnose subclinical infections at 
the quarter, cow or herd level (Newbould, 1984; Cullor and Tyler, 1996).
1.6.1. Milk sample collection
In order to diagnose mastitis pathogens accurately, milk samples need to be taken 
carefully (Watts, 1990). Poor sampling technique often leads to contamination of 
milk samples and confusion over the significance of the organisms isolated (Buswell,
1995).
1.6.2. Diagnostic tests
1.6.2.1. California Mastitis Test
The California Mastitis Test (CMT) is an indirect method of estimating SCC and is 
based on a gelling reaction between the nucleic acid of the somatic cells and an 
anionic surface active agent with bromcresol-violet as an indicator (Scalm and 
Noorlander, 1957; Philpot, 1984; Bramley, 1992; Radostits and others, 1994b; 
Muldoon, 1995). Although not very sensitive or specific, the CMT is a practical and 
useful on-farm test to identify individual cows with subclinical mastitis (Jaartsveld, 
1975). This test is not sensitive enough for bulk milk samples: the results are usually 
negative or a small amount of gel formation occurs, so that automated SCC should be 
used for assessment of bulk milk (Cullor and Tyler, 1996).
1.6.2.2. Bacteriology and somatic cell counting
Bulk milk sampling is a practical means o f monitoring a herd for potential mastitis 
pathogens, but obviously is far less sensitive than culturing individual quarters 
(Lawrence, 1997). Bulk milk bacteriological examinations have a high specificity 
but low sensitivity as a test for mastitis, meaning that some infected herds may not be 
detected on bulk milk samples (Godkin and Leslie, 1991). Biggs (1996) 
recommends that bacteriology is performed on bulk milk and, as necessary, from
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selected high ICSCC cows. An infected quarter is defined as one producing milk 
from which bacteria are recovered in pure culture and in which there is an increased 
number of leucocytes, compared to a normal quarter of the same cow (Newbould, 
1984). Sears (1993) suggests that ICSCC > 300,000 cells/ml should be used as a 
guideline for sampling for bacteriological culture. Sampling high ICSCC cows 
increases the efficiency o f bacteriological cultures (Erskine and Eberhart, 1990; 
Logue, 1997). Cows infected subclinically may be cyclic shedders of organisms and 
may vary between low and high shedding patterns throughout a lactation (Sears and 
others, 1990; Sears and others, 1993; Shukken and others, 1993). The daily variation 
in shedding of bacteria, in certain cows, has been reported to fluctuate by a hundred 
fold (Lawrence, 1997). The accepted criterion for diagnosis o f intramammary 
infection is that intramammary infection exists when the same organism is isolated 
from two, or two out o f three, consecutive samples taken at least one day apart (Sears 
and others, 1993). Twenty five percent of S. aureus infected cows will have a 
negative single culture result i.e. false negative, but with repeated sampling 
sensitivity is increased to 94-98% (Sears and others, 1993). Observations in 
Minnesota have shown that, in order to eliminate false negatives attributable to the 
daily variation in shedding o f S. aureus, milk samples need to be taken for four 
consecutive days (Farnsworth, 1993). However, Erskine and Eberhart (1988) 
compared duplicate and single samples taken for mastitis pathogen identification and 
found a high level of agreement for the contagious pathogens, but a high level of 
disagreement for the environmental pathogens. Duplicate samples should be taken 
within one week of each other to reduce the chance o f missing new infections 
(Neave, 1975). Therefore, a single sample culture is acceptable for the identification 
of contagious pathogens, such as S. aureus and S. agalactiae, allowing savings on 
labour and laboratory costs (Erskine and Eberhart, 1988). However, neither single 
nor duplicate samples offer a high degree o f accuracy in identification of 
intramammary infection with environmental pathogens. This is thought be due to the 
low numbers o f environmental pathogens in the milk (Neave, 1975) and the fact that 
contamination is likely to be due to the environmental reservoir o f infection (Smith, 
1983). In order to improve the accuracy of diagnosis in environmental mastitis, 
repeated cultures with larger volumes o f milk (> 0.01 ml) and CMT should be used
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in conjunction with a consideration o f clinical signs, appearance of milk and ICSCC 
(Erskine and Eberhart, 1988).
Bacteriological examination of bulk milk and, if  necessary, milk from high ICSCC 
cows, should be carried out to check for S. agalactiae infection in a herd (Biggs,
1996). Biggs (1996) found that if  S. agalactiae infection was widespread among 
cattle in a herd, such that BMSCC was > 500,000 cells/ml, then S. agalactiae was 
usually readily isolated from bulk milk samples. Quarters infected with S. agalactiae 
usually shed high numbers of bacteria, but occasionally so few organisms are shed 
that a single sample can be negative on culture (Dinsmore and others, 1991). 
Underlying S. agalactiae infection may be masked if a heavy growth of another 
pathogen is cultured (Biggs, 1996).
1.7. Pathogenesis
1.7.1. General
The primary defence mechanism of the mammary gland is the teat canal, as this 
represents the portal o f entry for nearly all mastitis-causing micro-organisms 
(Bramley and Dodd, 1984; Craven and Williams, 1985; Nickerson, 1985; Sandholm 
and others, 1990; Bramley, 1992; Vestweber and Leipold, 1993). Injury to the teat 
end and teat canal almost always leads to intramammary infection (Benedixen, 1935; 
Ferguson, 1944; Smith and Hogan, 1996). The development o f intramammary 
infections occurs by the contamination o f the teat end with pathogenic organisms 
(Tolle, 1975; Bramley and Dodd, 1984) followed by penetration into the teat canal 
and the colonisation by the organisms in the sinuses, ducts or alveolar tissue 
(Kingwill, 1980; Bramley and Dodd, 1984). Any infection gaining access to the 
gland must remain adherent to the inner surfaces, despite the out-flow o f milk, and 
escape the action o f the defence mechanisms (Reichmuth, 1975). The division o f the 
udder into four independent quarters helps to restrict the spread o f infection 
(Reichmuth, 1975). However, the transfer of some pathogens between quarters is 
inevitable at milking time, even under the best hygienic conditions (Philpot, 1975).
24
Most infections which occur in the dry period develop in the first two or three weeks 
after drying off and are thought to be due to pathogens remaining in the udder from 
the milking period (Philpot, 1975).
1.7.2. Staphylococcus aureus
There is considerable variation in the type o f mastitis caused by S. aureus, this is not 
thought to be attributed to differing virulence between strains. Instead, it appears to 
be related to the infective dose or the lactational status of the cow (Bramley, 1992; 
Radostits and others, 1994a). Infection early in lactation tends to result in peracute 
mastitis, whereas infection later on or in the dry period results in acute or chronic 
infections (Radostits and others, 1994a). Peracute mastitis results from the 
uncontrolled growth o f the organism (Bramley, 1992) and leads to thrombosis of the 
mammary veins which produces local oedema and congestion of the udder. 
Toxaemia arises from the release o f bacterial toxins and tissue destruction (Radostits 
and others, 1994a). Acute and chronic mastitis differ depending on the degree of 
involvement o f the mammary tissue. The proliferation of bacteria in the collecting 
ducts occurs in both acute and chronic mastitis, but in acute mastitis fibrin clots 
block the ducts causing severe reaction in the obstructed area (Radostits and others, 
1994a). In contrast, in chronic infections reactions are restricted to the epithelium of 
the ducts (Radostits and others, 1994a). Abscesses, granulomas and fibrosis develop 
in some S. aureus infections (Bramley, 1992; Radostits and others, 1994a). 
Staphylococcus aureus can survive within polymorphonuclear leucocytes, 
macrophages and epithelial cells and is thus protected to some extent from some 
antibiotics (Sandholm and others, 1990; Bramley, 1992).
1.7.3. Streptococcus agalactiae
Streptococcus agalactiae does not enter the glandular tissue but is restricted to the 
epithelial surfaces (Sandholm and others, 1990; Radostits and others, 1994b) and, 
therefore, is more accessible to antibiotics and the host’s own immune mechanisms.
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1.8. Treatment
1.8.1. General
In order to treat mastitis successfully, a drug must maintain an effective dose, i.e. 
exceed the minimum inhibitory concentration (MIC), for an adequate period o f time 
(Bramley and Dodd, 1984; Ziv, 1992). Furthermore, to achieve maximum 
penetration, antibiotics should be lipid soluble, non- or weakly ionised in milk, and 
not readily bound by serum or milk proteins (Bramley and Dodd, 1984; Sandholm 
and others, 1990). Many antibiotics are less effective in milk than suggested by 
antibiotic sensitivity plates (Sandholm and others, 1990; Blowey and Edmondson,
1995). A choice can be made between bactericidal antibiotics which kill bacteria, 
and bacteriostatic antibiotics which prevent bacterial growth and multiplication and 
rely on the cows own defence mechanisms to overcome the infection (Blowey and 
Edmondson, 1995). Although ostensibly more attractive, bactericidal antibiotics may 
cause sudden bacterial death and release o f endotoxins leading to further problems 
(Blowey and Edmondson, 1995). The cost o f the treatment and the length o f milk 
withdrawal periods should be considered when choosing an antibiotic for mastitis 
therapy (Blowey and Edmondson, 1995). It is difficult to find an antibiotic which 
will satisfy all the desired criteria, and some that do so may be either too expensive 
or reserved for human use (Bramley and Dodd, 1984). With intramammary 
treatment, the majority of the antibiotic tends to remain within the treated quarter, but 
some will diffuse into the blood, circulate around the body and be deposited into 
untreated quarters: therefore the milk from all quarters should be withheld from the 
bulk tank for the prescribed withdrawal period for that particular preparation 
(Blowey and Edmondson, 1995). However, the withholding of milk from all 
quarters of a cow which has been treated with an intramammary preparation is a legal 
requirement anyway. Treatment efficacies for intramammary infections during 
lactation reported by Smith and Hogan (1996) were: 80-90% for S. agalactiae, 50- 
60% for coagulase negative staphylococcal infections, 50% for environmental 
streptococcal infections, 30-50% for S. aureus, < 10% for gram negative infections 
and no response was seen in infections caused by yeasts, moulds, Mycoplasma spp. 
and Protothea spp.. Similar cure rates were recorded by Huber (1977): 100% for S.
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dysgalactiae, 98% for S. agalactiae, 82% for Streptococcus uberis and only 35% for
S. aureus. Therapy is more effective in the dry period than during lactation, and is 
more effective after the first clinical episode, i.e. in heifers, than after repeated 
treatments, i.e. older cows (Sandholm and others, 1990; Meany, 1992; Lawrence,
1997). Spontaneous recoveries often equal the number of infections eliminated by 
antibiotic therapy in lactating cows (Griffin and others, 1982), but spontaneous 
recoveries often take a long time i.e. there will be a prolonged period of infection 
before recovery occurs (Bramley and Dodd, 1984). The proportion o f spontaneous 
elimination is low for staphylococcal infections at < 20%, high for Escherichia coli 
at > 70%, and intermediate for streptococcal infections (Bramley, 1992). Dodd and 
Griffin (1975) reported that 90% of staphylococcal infections that did not receive 
antibiotic therapy persisted for three months, and that over 80% of staphylococcal 
infections present at drying-off persisted until calving. Bramley and Dodd (1984) 
found that in most clinically infected quarters a response is seen within one or two 
days of antibiotic therapy, and in the majority the infection is eliminated.
Treatment of lactating cows with antibiotics, based on increased SCC or 
bacteriological culture o f milk, is not always considered to be cost-effective 
(Yamagata and others, 1987). This is mainly due to the fact that milk production 
does not always improve in response to antibiotic therapy: Staphylococcus aureus 
infections respond poorly to antibiotics and some organisms are cleared from the 
mammary gland without therapy (McLeod and Wilson, 1951). Two suggested 
approaches to improve the bacteriological cure in lactating cows are, (1) increasing 
the duration o f treatment with intramammary infusions or, (2) combining 
intramammary infusions with parenteral antibiotics (Lawrence, 1997). In a study 
comparing the efficacy of three different treatment regimens, Jarp and others (1989) 
showed that the duration of the treatment is more important than the route of 
administration in curing cases o f mastitis.
1.8.2. Objectives of mastitis treatment
Treatment of mastitis is carried out for many reasons: (1) to treat clinical infections 
in order to regain normal milk secretion, prevent progression o f the disease and
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improve the welfare o f the cow, (2) to eliminate clinical or subclinical infections, or 
at least reduce their number and frequency, so that the milk yield from the herd is 
improved, (3) to prevent the spread of infection, by eliminating the main source of 
bacteria, in the case of infectious organisms, (4) to prevent development of infection 
in an animal or herd exposed to a particular or temporary risk, and/or (5) to avoid 
penalties imposed by milk purchasers for milk with high SCC (Plommet and 
LeLouedee, 1975; Blowey and Edmondson, 1995).
1.8.3. Antibiotics
The intramammary route is a practical, inexpensive and convenient route for the 
treatment of bovine mastitis (McKellar, 1991; Vestweber 1993). However, in acute 
severe disease, the distribution of intramammary antibiotics may be impaired by 
inflammation within the udder, and therefore parenteral antibiotics may be necessary 
(Sandholm and others, 1990; Prescott and Baggot, 1993). The choice o f antibiotic 
will depend on the in vitro sensitivity of the organism, and it should be remembered 
that the sensitivity may change over a period of time, especially following intensive 
antibiotic usage, and also with geographic location (Owens and Watts, 1988; 
McKellar, 1991). The antibiotic for mastitis therapy should be chosen after 
considering the activity and pharmacodynamics of the drug, the probable cause of 
mastitis, the milk withdrawal period, (McKellar, 1991) and the cost, though the cost 
of discarded milk is often considered to be more important than the cost o f the 
antibiotic (Prescott and Baggot, 1993).
Streptococcus agalactiae (Chapter 1.5.2) is highly sensitive to penicillin and this 
would be the drug of choice to treat S. agalactiae infections (Sandholm and others,
1990). However, S. aureus (Chapter 1.5.1.) infections pose more problems. Dodd 
and others (1964) reported approximately 70% of S. aureus isolates causing mastitis 
to be resistant to penicillin. Wright (1983) also found 51% of S. aureus isolates to be 
resistent to penicillin. Nafcillin and cloxacillin are modified penicillins which are 
effective against p-lactamase producing S. aureus but, like penicillin, they have no 
action against gram-negative organisms (McKellar, 1991; McKellar, 1996). There 
are modified penicillins, ampicillin and amoxycillin, which are effective against
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gram-negative and gram-positive organisms, but are inactivated by P-lactamase 
producing S. aureus (McKellar, 1991). Clavulanic acid combined with amoxycillin 
provides irreversible inhibition o f P-lactamase produced by S. aureus, therefore 
producing an antibiotic with activity against the vast majority o f mastitis causing 
organisms (Sandholm and others, 1990; McKellar, 1991; McKellar, 1996). 
Cephalosporins have activity against gram-negative and gram-positive organisms as 
well as p-lactamase producing S. aureus, however, udder penetration by these drugs 
is not as good as with penicillins (Blowey and Edmondson, 1995). Macrolides such 
as erythromycin penetrate the udder well and have good activity against gram- 
positive organisms, including P-lactamase producing S. aureus (Ziv, 1980; Sandholm 
and others, 1990; McKellar, 1991; Prescott and Baggot, 1993). Aminoglycosides 
such as streptomycin, dihydrostreptomycin and neomycin are often combined with 
penicillins as they have good activity against coliforms and P-lactamase producing S. 
aureus, but have poor udder penetration (Barragry, 1994). Tetracyclines are broad 
spectrum and have good activity against gram-negative and gram-positive organisms, 
including some action against p-lactamase producing S. aureus, but udder 
penetration is limited and strains of resistant coliforms may develop (Barragry, 
1994). Novobiocin is a narrow spectrum antibiotic with excellent action against S. 
aureus, which also has synergistic properties when combined with penicillin 
(McKellar, 1991; Prescott and Baggot, 1993; McKellar, 1996).
In human medicine, penicillin resistant S. aureus infections are also a problem, and 
treatments of choice would be cloxacillin or flucloxacillin, with possible alternatives 
being first generation cephalosporins, amoxycillin/clavulanic acid combinations or 
erythromycin (Tumidge and Grayson, 1993). In a study by Efrat and others (1995) it 
was found that 85% of cases of mastitis in human neonates were due to S. aureus 
infections, and 50% of infections responded to intravenous cloxacillin or 
amoxycillin/clavulanic acid combination. Brglez and others (1988) reported S. 
agalactiae infections in humans with the most severe cases occurring in the perinatal 
period, causing abortions and infections in the neonates: with the mother being the 
main source of infection.
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Owens and others (1988) showed that in the cow the combination o f parenteral 
procaine penicillin with intramammary infusions o f amoxycillin was more 
efficacious than intramammary amoxycillin alone in the treatment o f subclinical S. 
aureus. The combination of parenteral and intramammary antibiotics produced a 
bacteriological cure in 51% of quarters and 48% of cows, whereas intramammary 
treatment alone gave cure rates of 25% of quarters and 30% of cows. The reduced 
patency o f the duct system due to chronic inflammation may contribute to the poor 
response to intramammary treatment seen in S. aureus infections, as intramammary 
antibiotics must diffuse through the milk into the terminal alveoli through the ducts 
(Craven and Anderson, 1979).
Corticosteriods are often added to antibiotics in intramammary preparations to reduce 
inflammation in the udder tissue. Prednisolone has not been shown to adversely 
affect the function of white blood cells in the udder, despite being proven to be 
immunosuppressive in other parts o f the body (McKellar, 1991). Experiments by 
Bywater and others (1988) showed that prednisolone effectively increased the rate of 
reduction of the swelling seen in mastitis with no effect on SCC in milk.
As non-lactating (dry) mammary glands are believed to be naturally resistant to 
gram-negative organisms, due to the production o f lactoferrins, dry cow therapy 
(Chapter 1.9.1.) is aimed at eliminating intramammary infections caused by S. aureus 
and S. uberis. However, Green and Bradley (1998) have found that new infections of 
E. coli have been acquired in the dry period. Actinomyces pyogenes should be 
targeted if  summer mastitis is a problem (McKellar, 1991).
1.9. Control
Smaller profit margins experienced in dairy farming in recent years mean that 
producers need to be more efficient, and any mastitis control needs to be cost 
effective (Smith and Hogan, 1996). In order to be effective, a control system should 
be practical and economic (Wilson and Kingwill, 1975; Radostits and others, 1994b) 
and needs to be continually monitored (Dodd, 1980). Effective and economical
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controls for mastitis should rely on prevention rather than treatment (Wilson and 
Kingwill, 1975; DeGraves and Fetrow, 1993; Erskine, 1993). Mastitis control relies 
on reducing the exposure o f teat ends to pathogens (Bramley, 1980; Cullor and Tyler, 
1996; Smith and Hogan, 1996) and/or increasing the resistance o f cows to infection 
(Cullor and Tyler, 1996; Smith and Hogan, 1996).
1.9.1. ‘Five Point Plan’
A comprehensive control programme, correctly applied, reduced the occurrence of 
mastitis by 50% over one year, and by 75% over two to three years in a number o f 
herds (Philpot, 1984). An effective control programme should include good hygienic 
practise and good management, as specific control measures are not thought to be a 
substitute for good husbandry (Jackson, 1980).
Success in reducing the exposure o f teat ends to infection has followed the 
application of the so-called ‘Five Point Plan’, which was developed to control 
contagious pathogens in the dairy herd. The ‘Five Point Plan’ was devised by the 
National Institute for Research in Dairying (NIRD), Central Veterinary Laboratories 
(CVL), Ministry of Agriculture, Fisheries and Food (MAFF), British Veterinary 
Association (BVA), National Farmers Union (NFU), Agricultural Training Board 
and the Association of British Pharmaceutical Societies in November 1971 to attempt 
to control mastitis in commercial dairy herds (Booth, 1975a). Originally the control 
regime consisted o f six points:
1. Good stock control.
2. Good milk hygiene, specifically thr use o f post-milking teat disinfection.
3. Prompt treatment of clinical cases and the use of dry cow therapy (DCT).
4. Culling chronic or recurrent cases.
5. Monitoring progress of control measures by cell counting.
6. Regular testing and maintenance o f the milking machine.
31
Booth (1975b) later adapted these points to make the ‘Five Point Plan’, which 
consists of:
1. Post milking teat dipping,
2. Total dry cow therapy (DCT),
3. Proper maintenance and operation o f the milking machine,
4. Prompt therapy o f clinical cases when they occur and
5. Culling chronic cases.
If hygienic methods are to be o f value in reducing the incidence of new infections, 
they must prevent, or at least greatly reduce, the transmission of pathogens from one 
teat to another o f the same cow, as well as from cow to cow (Philpot, 1975). The 
reservoir of contagious pathogens can be reduced by DCT, culling, and, to a lesser 
degree, treatment o f clinical cases during lactation (Smith and Hogan, 1996). A high 
BMSCC caused by S. agalactiae infection have proved to be the most responsive to 
control, whilst those involving S. aureus infection alone have been generally 
unresponsive to any control measures other than selective culling (Logue, 1997). 
Surveys by Smith and Hogan (1993) and DeGraves and Fetrow (1996) showed that 
washing udders, single use paper towels, changing cluster liners, post milking teat 
dipping and DCT were cost-effective improvements to aid the control of mastitis. 
Good control o f subclinical mastitis can be achieved with post-milking teat dipping 
and DCT of known infected quarters. A marked reduction in S. agalactiae and S. 
aureus infections have been seen using this regime (Natzke, 1981; Dodd, 1983; 
Smith, 1983; Smith and Hogan, 1996). High SCCs, repeated clinical cases and 
occasional isolation o f S. aureus are typically suggestive of poor elimination of 
infection by lactating or dry cow therapy (Bramley, 1992).
1 .Post milking teat disinfection.
Post milking teat disinfection is recommended as an effective means to destroy 
bacteria left on the teat after milking, preventing teat lesions or assisting the healing 
of teat lesions, and in the control o f teat duct bacterial colonisation (Bramley, 1980; 
Bramley and Dodd, 1984; Bramley, 1992). Trials performed by Neave and others 
(1966) showed that post milking teat disinfection combined with the use of
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individual paper towels or cloths, reduced the incidence o f new infections by 50 %.
2. Dry cow therapy.
The aim of DCT is that it is to be used in all quarters o f all cows in a herd at drying 
off to eliminate existing infections and to prevent intramammary infection during the 
dry period (Neave and others, 1966; Costa and others, 1996; McKellar, 1996). The 
response to treatment in the dry period is more complete than during lactation. This 
may be due to the freedom to use higher doses of antibiotics and/or to use long acting 
preparations when milk withdrawal periods are generally not a concern (Wilson, 
1980; Barragry, 1994). The use o f DCT is relatively inexpensive as there is no need 
to discard milk due to antibiotic contamination (Wilson, 1980). Dry cow therapy is 
very effective in eliminating S. agalactiae infections and 80-90% cure rates can be 
achieved for Streptococcus spp. (Philpot, 1984; Barragry, 1994). Staphylococcus 
aureus infections are also much more effectively controlled using DCT with cure 
rates of 70-80% compared to 30-40% for infections treated during the lactation 
period. (Philpot, 1984).
3. Milking machine.
There should be regular inspections o f the milking machine, as the milking machine 
is known to influence the incidence o f mastitis (Neave and others, 1966; Sandholm 
and others, 1990; Bramley, 1992). Kirk (1990) stated that improperly functioning or 
designed milking equipment, especially in conjunction with poor milking technique 
and hygiene, could greatly increase the level of mastitis in a dairy herd.
4. Prompt therapy o f clinical cases.
Clinical cases should be treated promptly to reduce the risk o f chronic infection and 
to maintain the BMSCC and TBC below the acceptable limits. Milking mastitic 
cows into the bulk tank can lead to wild fluctuations in TBC (David and Jackson, 
1984) and result in the BMSCC exceeding the EC standard o f < 400,000 cells/ml.
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5. Culling chronic cases.
Culling of all infected cows, especially younger or high producing animals, is not 
usually cost effective or practical (Bramley and Dodd, 1984; Hoblet and Miller,
1991), but may prove to be advantageous in the long term, depending on the 
pathogen involved (DeGraves and Fetrow, 1996). Culling is recognised as a valuable 
method of reducing the spread and, in some instances, eliminating certain infectious 
diseases (Natzke and Everett, 1975). However, culling should not be based on the 
results of a single sample, whether it be SCC or bacteriological, due to variations in 
shedding (Chapter 1.6.2.2.) and the possibility of natural elimination of certain 
pathogens (Blowey and Edmondson, 1995). A cow with persistently increased SCC,
i.e. > 250,000 cells/ml for three consecutive monthly samples, should be considered 
for culling. When making a decision to cull other factors should also be considered, 
such as the number of cows in the herd in the same category, the number of times the 
cow has had mastitis in the current and previous lactations, which organisms are 
involved, milk yield, reproductive status (Reneau, 1993), general health and the 
source of replacements (Blowey and Edmondson, 1995). The economics involved in 
the culling of high SCC cows is complex, as the replacement cost and the reduction 
in milk yield o f a heifer compared to a mature cow need to be considered (Bramley 
and Dodd, 1984; Hoblet and Miller, 1991; Reneau, 1993). It is possible that a cow 
with chronically high SCC could live comfortably within the herd and could be cured 
by DCT, but may often be culled for economic reasons. In this way, the direct cost 
of mastitis treatment will be avoided and a potential source o f infection for the rest 
herd will be removed (Blowey and Edmondson, 1995). However, segregation of the 
infected cows, or the use of separate milking units for cows infected with S. aureus 
can reduce the prevalence of infection and reduce the BMSCC, and should not be 
forgotten as a means of mastitis control (Wilson, 1980).
1.9.2. ‘Blitz therapy’
‘Blitz therapy’ is the programmed, simultaneous treatment of all four quarters of 
cows with intramammary antibiotics aiming to eliminate S. agalactiae infection 
(Roberts and others, 1969). ‘Blitz therapy’ can be done on a whole herd basis, where 
the entire milking herd undergo treatment, or on a partial herd basis, where only
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selected animals are treated (Blowey and Edmondson, 1995). With adequate case 
selection, response to therapy is good and the milk withdrawal periods o f the drugs 
commonly used can be short, meaning that this approach can be an economic 
proposition in a badly infected herd (Yamagata and others, 1987). ‘Blitz therapy’ 
should be based on individual quarter or composite bacteriological milk samples 
(Erskine and Eberhart 1990), as SCC are not a good indicator of the precise 
diagnosis, even though high SCC correlates well with S. agalactiae infection 
(Blowey and Edmondson, 1995). Herd screening will also identify which cows are 
infected with other contagious pathogens, will give an indication o f the expected 
SCC response after treatment and will indicate whether further measures may be 
necessary (Biggs, 1996). The choice between total or partial herd blitz therapy 
depends on the prevalence of infection within the herd (Biggs, 1996). Total herd 
‘blitz therapy’ gives faster, more predictable results and is more straightforward 
(Biggs, 1996). However, in herds with a low prevalence of infection, or if  the SCC 
penalties are minimal, then the longer term, less aggressive approach of the partial 
‘blitz therapy’ may be more appropriate and economical (Biggs, 1996). There are 
reduced costs with partial ‘blitz therapy’, i.e. fewer intramammary tubes and less 
milk to discard than if the whole herd were treated simultaneously. However, the 
necessary repeated herd screening, and treatment of infected cows, as infection 
spreads during the delay between sampling and treatment may make partial blitz 
therapy more costly than total herd treatment (Biggs, 1996). A single intramammary 
treatment is thought to be sufficient to eliminate S. agalactiae, but, as demonstrated 
in a study by Biggs (1996), some herds need a course of treatment. Biggs (1996) 
used a single dose of an intramammary preparation containing 1 g of penicillin G and
0.5g of dihydrostreptomycin (Streptopen MC, Schering-Plough Animal Health, 
Uxbridge) to successfully eliminate S. agalactiae infection from treated herds. 
Purchased animals should ideally be treated prior to entry into a herd which has been 
‘blitzed’ so as to prevent re-introduction o f infection into the herd, unless the herd 
from which the animals were purchased has a low BMSCC and/or is known to be 
free of S. agalactiae infection (Biggs, 1996).
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The economic value o f treating late lactation cows is questionable, as it will be 
unlikely that the yield will improve by a sufficient amount to cover the cost of 
treatment (Yamagata and others, 1987). However, failure to treat these cows could 
leave a reservoir o f infection in the herd (Blowey and Edmondson, 1995).
Following whole herd or partial herd ‘blitz therapy’, the milk will need to be 
withheld for the statutory period, which varies depending on the drug used. During 
this time the farmer will not receive income from milk. It should be remembered that 
the milk withdrawal period is yield dependent, therefore in some smaller, low- 
yielding herds, the threshold used for calculating the length o f milk withdrawal may 
be exceeded (Blowey and Edmondson, 1995). Arrangements for testing the milk for 
antibiotic residues prior to collection should be recommended (Blowey and 
Edmondson, 1995).
‘Blitz therapy’ can fail due to the introduction o f new cows into the herd (Roberts, 
1969), careless milking hygiene allowing residual infection to be transferred from 
cow to cow, failing to use DCT on all dry cows and, if  a partial ‘blitz’ regime is 
being used, failing to identify all infected cows, (Biggs, 1996). Persistence of 
infection could be due to ineffective treatment of existing cases; whereas new 
intramammary infections could arise due to poor control or hygiene measures 
(Blowey and Edmondson, 1995). Good milking routine is essential for the success of 
‘blitz therapy’, as it has been reported that infection levels can return to those present 
prior to treatment within one or two years if  a poor milking routine persists (Biggs,
1996). Hygiene is also important in preventing other pathogens taking the place o f S. 
agalactiae following ‘blitz therapy’ (Roberts and others, 1963). Isolation o f S. 
agalactiae, following total ‘blitz therapy’, indicates inadequate teat disinfection 
and/or DCT, or the introduction of an infected animal (Bramley, 1992).
The major advantage o f ‘blitz therapy’ is the rapid reduction in the prevalence of 
infection and SCC compared to the enforcement of a control programme of teat 
dipping and DCT (Erskine and Eberhart, 1990).
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1.9.3. Eradication
Elimination of infection from cows can be achieved by (1) the defence mechanisms 
of the udder eliminating the pathogen i.e. spontaneous cure, or (2) by treatment 
during lactation, or (3) by the treatment during the dry period, or (4) by culling 
infected animals (Bramley and Dodd, 1984). The diligent application of proven 
control measures reduces the incidence of mastitis due to Staphylococcus spp. and 
Streptococcus spp. However, it is possible to eradicate S. agalactiae from herds and 
three options are available. (1) total herd ‘blitz therapy’, (2) partial herd ‘blitz 
therapy’, and (3) improved dairy management (Biggs 1996). Blitz therapy has 
already been discussed (Chapter 1.9.2.). Biggs (1996) considers S. agalactiae too 
contagious to control by improved management alone. However, Bramley and Dodd 
(1984) believe it would be uneconomical to strive for eradication o f the common 
major pathogens, even Streptococcus agalactiae, due to the cost o f laboratory 
services and because there are now effective control measures which will reduce the 
level of infection to very low levels. Eradication of one infectious agent is useless if 
it is followed by a rise in the rates of others. Therefore before carrying out ‘blitz’ 
treatment, it is recommended to adopt a scrupulous milking routine and maintain 
adequate hygiene standards (Roberts and others, 1963). If hygiene is not maintained 
at an adequate level there is a risk that S. agalactiae will be re-introduced into the 
herd, and as the herd will be completely naive following a ‘blitz therapy’, the 
organism would spread rapidly between cows.
Unlike most infections with Streptococcus spp., S. aureus infections are very difficult 
to eradicate, which is due to the fact that Staphylococcus spp. invades tissue and 
intramammary infusions may be unable to gain access to the organism (Ziv, 1980). 
Therefore eradication is often not attempted but a reduction in S. aureus infections 
may follow enforcement o f the ‘Five Point Plan’ and culling of infected cows, where 
possible.
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1.10. Impact
Despite rigorous implementation o f the ‘Five Point Plan’ giving good control of 
subclinical mastitis by post-milking teat disinfection and DCT, the prevalence of 
clinical mastitis may remain unaltered (Eberhart and Buckalew, 1977). However, a 
change in the organisms responsible for the clinical cases may be seen (Erskine and 
Eberhart, 1988). Environmental pathogens are becoming more important as major 
causes of bovine mastitis, as the incidence o f contagious pathogens reduces (Booth,
1993). Shukken and others (1989) have demonstrated in low BMSCC herds, that teat 
disinfection after milking increases the percentage o f uninfected quarters and 
increases the risk o f clinical mastitis. This may be because teat dipping and DCT are 
least effective against environmental pathogens (Natzke, 1981; Oliver and Mitchell, 
1984) or because the presence of minor pathogens tends to prevent the multiplication 
of major pathogens (Brooks and Bamum, 1984; Shukken and others, 1989). Reports 
by Dodd (1983) and by Oliver and Mitchell (1984) have also shown that the 
prevalence o f environmental mastitis has increased, especially in low SCC herds. 
These authors found that environmental pathogens made up more than eight to nine 
times the percentage o f isolates in S. agalactiae negative herds as compared to S. 
agalactiae positive herds. As it is difficult to interpret herd survey data on coliform 
infections, the prevalence of these is probably underestimated. Miltenberg and others 
(1996) reported that, in Southern Netherlands, a high prevalence o f clinical mastitis 
is a problem in herds with low BMSCC. These increasing cases o f severe mastitis 
tend to be associated with E. coli infections (Wilesmith and others, 1986). This 
alteration in the relative importance of the organisms associated with clinical mastitis 
may be due to management changes and adoption o f mastitis control measures as E. 
coli and Streptococcus uberis infections are more prevalent than 15 years ago 
(Wilesmith and others, 1986). Therefore, the statement that 85-95% of bovine 
mastitis cases are caused by S. aureus and S. agalactiae, should be qualified by 
adding that this is likely to be the situation in herds which do not carry out post­
milking teat dipping or DCT (Eberhart and Buckalew, 1977; Oliver and Mitchell, 
1984).
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1.11. Prevention
1.11.1. Genetics
There has been an increasing interest in breeding cattle for reduced susceptibility to 
mastitis (Shook, 1993). A survey by Hibbitt and others (1980) suggested the 
existence of a relationship between genetics and the prevalence of mastitis. Hamori 
(1980) demonstrated that cows selected for high dairy performance, had enormous 
bulky udders and were more liable to incur injuries, and therefore mastitis was more 
likely. Shook (1993) reported a positive relationship between milk yield and 
mastitis, suggesting that the genes for increased milk yield also tend to increase the 
susceptibility to mastitis. Another predisposing factor to the development o f mastitis 
was found to be the conformation o f the teat and teat orifice and broad patent teat 
canals with inadequate sphincter muscles were seen to facilitate ascending invasion 
of infectious agents (Hamori, 1980). However, the factors allowing teat canal 
penetration may also be associated with low milk yield and slow milking (Bramley 
and Dodd, 1984). Shook (1993) recommended the use o f SCC as an indicator trait 
for genetic improvement for mastitis resistance. However, genetic improvement for 
SCC will not replace the requirement for good herd management to reduce mastitis 
(Hansen, 1993).
1.11.2. Vaccination
Vaccines against S. aureus mastitis are available in the USA. However, these 
vaccines do not prevent all infections, and if  infected cattle remain in the herd, they 
will act as a reservoir of infection and segregation of infected cows would be 
necessary (DeGraves and Fetrow, 1993). The bacterin appears to reduce the 
frequency and severity o f clinical episodes o f Staphylococcus aureus infections, but 
is unlikely to have any great impact on the incidence or prevalence o f infections 
(Tyler and others, 1993). Given the efficacy of inexpensive antibiotics, and the ease 
of eradication o f S. agalactiae, a bacterin for S. agalactiae would need to be highly 
efficacious before its use would be recommended (DeGraves and Fetrow, 1993). It 
is, therefore, unlikely that commercial vaccines against the main contagious 
pathogens will become available in the UK in the near future.
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1.12. Approach to the investigation of a problem farm
Herd mastitis investigations can be divided into three major stages (David, 1993):
1. Assessment o f herd data,
2. The farm visit and,
3. Plan of action, formed after evaluation o f herd data and the on-farm situation.
Mastitis is noted as being a problem by the farmer when there is an increase in the 
incidence of clinical mastitis, or an increase in BMSCC, or an increase in bulk tank 
TBC or bactoscan, or any combination o f these factors (Bushnell, 1980; David,
1993). In addition to these factors, mastitis cases which are slow to clear, repeated 
periodic bouts o f clinical cases, and cases recurring soon after treatment may also 
encourage the farmer to seek veterinary advice (Watson, 1998). The examination of 
herd records may indicate whether environmental or contagious pathogens are likely 
to be the problem (Blowey, 1984; David, 1993). The clinical records are also the 
most accurate measure of the incidence o f mastitis in a herd (David and Jackson, 
1984). Repeated clinical incidents in the same cows are suggestive of a chronic S. 
aureus problem, whereas a situation where there are large numbers o f cows with new 
infections suggests environmental pathogen involvement (David, 1993). The time 
and duration o f infection in relation to the stage of lactation are also useful in 
determining the nature of the infection (Blowey, 1984; David, 1993). Environmental 
infections tend to be more common in freshly calved cows, whereas contagious 
pathogens tend to cause mastitis at any stage of lactation (David, 1993). 
Bacteriological examination of milk samples is one of the most important 
components of a mastitis investigation (David, 1993), and monthly culture o f bulk 
milk samples is a practical and economical procedure to monitor mastitis at the herd 
level (McDonald, 1989; Biggs, 1996). Bulk milk culture is also useful as a post­
treatment check (Biggs, 1996). The identification of the causal pathogen is 
fundamental in an investigation o f a mastitis problem as it allows areas requiring 
investigation to be identified, i.e. the environment or the milking plant, and 
consequently which control measures should be focused on (David and Jackson,
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1984). Trends in BMSCC (Jackson, 1980), ICSCC and TBC provide useful means 
to follow the pattern of infection.
A farm visit to assess the milking machine design and function, and the milking 
routine, as well as the environment and housing o f the cows is important to discover 
any factors predisposing to mastitis (Bushnell, 1980; Kirk, 1990; David, 1993). The 
general management of the herd, including stocking density, feeding and grouping, is 
also important (David, 1993).
After having evaluated the herd records and visited the farm, a decision on how to 
proceed may be made. Somatic cell counting and bacteriological examination at the 
cow or quarter level may be necessary. The CMT is a useful technique to make the 
bacteriological sampling more cost-effective (Bushnell, 1980). The steps taken to 
combat the problem will differ depending on the type of organism involved. If an 
environmental pathogen is involved, control measures may include: cleaning out and 
re-bedding the housing area and improving the drainage and ventilation (David,
1993). Drug treatment may be the intervention of choice for S. agalactiae, whereas 
treatment, segregation or culling may be advised for S. aureus (David, 1993).
1.13. Summary
Mastitis remains the most prevalent disease o f adult dairy cattle. Subclinical mastitis 
has increased in significance following the introduction of the EC Health and 
Hygiene Directive 92/46 in 1994. As milk companies can dictate the standards for 
milk quality prior to agreeing to purchase milk from the producer, as well as 
imposing penalties for inferior quality milk, the control of subclinical mastitis is an 
economic concern for the milk producer. Diagnosis o f infectious agents relies upon 
evaluation o f farm practices relating to milking and housing, and bacteriological 
examination o f milk samples to identify the causal organisms. Streptococcus 
agalactiae and S. aureus are still the most common isolates in dairy herds with poor 
hygiene practices. However, environmental pathogens are increasing in significance. 
The main approach to mastitis control and prevention remains a reliance on good
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milking practice and adherence to the ‘Five Point Plan’, as was the case 30 years ago. 
There has been increasing interest in vaccinating against mastitis pathogens and in 
improving genetics so as to increase the resistance of cows to mastitis.
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Chapter 2 
Investigation of a high somatic cell count dairy herd
2.1. Introduction
High BMSCCs are often associated with subclinical mastitis infections in the udder 
(Dohoo and Meek, 1982). Contagious mastitis pathogens are more likely to produce 
subclinical infections, and therefore a high BMSCC, than environmental pathogens 
(Blowey and Edmondson, 1995). Herd records, especially those recording clinical 
cases of mastitis, are useful in determining the likely cause of a mastitis problem. 
The clinical records provide the most accurate measure of the herd incidence of 
mastitis (David and Jackson, 1984). Streptococcus agalactiae and S. aureus are the 
major pathogens associated with subclinical infections in Scotland (Logue and 
others, 1994; Logue, 1997) and in Massachusetts (Oliver and Mitchell, 1984). 
Infected cows will have a decreased milk yield, as much as 10%, and there will also 
be additional treatment and labour costs, should the infection become clinical (Hale, 
1956; Winkler, 1982).
When investigating a mastitis problem, after examining herd records, it is important 
to observe the milking routine used on the farm and check the milking machine 
(David, 1993). In the diagnostic work-up, somatic cell counting will be useful at the 
bulk tank, individual cow and/or individual quarter level (Jackson, 1980; Sears, 
1993; Biggs, 1996). The CMT crudely identifies high SCC cows and can be used to 
improve the efficiency o f milk sample collection for bacteriological examination, i.e. 
only quarters giving a positive result on CMT may be sampled for bacteriological 
examination (Jaartsveld, 1975).
The management o f contagious mastitis problems depends on the bacteria involved. 
For S. aureus infections, treatment and eradication are very difficult, and the
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approach to a herd infected with S. aureus may include segregation and/or culling of 
infected cows (Wilson, 1980). Intermittent shedding of S. aureus complicates the 
diagnosis o f mastitis problems caused by this pathogen (Sears and others, 1993). In 
contrast, S. agalactiae can often be eliminated from herds (Philpot, 1975; McDonald, 
1977) as it is sensitive to most antibiotics and can only survive in the environment 
for a limited period (Plommet and LeLouedee, 1975). Control measures for the 
eradication o f S. agalactiae, therefore, usually involve strict adherence to the 'Five 
Point Plan' (Chapter 1.9.1.), and treatment o f infected cows or of the whole herd 
(Biggs, 1996).
2.2. Farm background
2.2.1. Livestock
This project was based on the investigation of a high SCC dairy herd consisting of 
sixty cows, mainly Holstein/Friesian and some Ayrshires. The cows were kept on a 
family-run farm of approximately 114 hectares. In addition to the dairy cows, there 
were 200 Scottish Blackface ewes, six beef suckler cows and one Blonde 
D'Aquitaine stock bull kept on the farm. In general, the dairy cows were small in 
body size and had a long hair coat especially over the udder.
2.2.2. Breeding policy
Artificial insemination (A.I.) was routinely used for all dairy cows, with natural 
service using the stock bull, being reserved for repeat breeders. Nine or ten heifers 
were introduced into the herd every year. These dairy replacements were usually 
home-bred, but, occasionally, calved heifers were purchased to maintain the herd 
size.
2.2.3. Housing and feeding management
Over the winter months, November to April, the cows were accommodated in 
cubicles. Dry cows, milking cows and in-calf heifers were housed together in the 
same cubicle house. The cubicles were in single rows and were not bedded with the 
cows lying on the concrete bases. The passageway in the cubicle house was scraped
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once daily using a tractor and yard scraper. A feed barrier allowed ad-lib access to 
silage during the housing period. During the housing period, the milking herd 
received a standard daily ration of 2 kg/cow of BOCM Pauls dairy concentrate (18% 
crude protein). Recently calved cows received an additional daily concentrate ration 
at a rate o f approximately 2 kg/cow, which was divided and fed in the byre during 
each milking for at least one month after calving. No additional feed allowances 
were made for higher milk yields.
2.2.4. The milking machine and the milking routine
The cows were milked in groups of 10 in a byre using a pipeline system. Ten cows 
were tied by the neck down either side o f the byre for the duration of the milking 
procedure. There was no collecting or holding yard and cows were returned to the 
cubicle house or the field immediately following milking.
There were no milk jars so the milk was carried directly from the cows into the bulk 
tank meaning that it was not possible to assess individual cow milk yield. This 
milking system had been in place for approximately 40 years. Individual 
components had been replaced over time and the milking machine had undergone 
annual inspection by technicians from the milk purchasing company. It was standard 
practice to replace the liners for the clusters every six months.
2.2.5. Herd records and culling policy
Herd records were very poor: important events such as calving dates, cases of 
mastitis and treatments administered were not recorded. The only form of records 
kept were the A.I. sheets giving the service dates. Cows were culled based on age, 
poor reproductive performance and recurrent cases o f clinical mastitis.
2.2.6. Mastitis treatment and dry cow therapy
On detection of clinical mastitis the farm policy was to infuse novobiocin, neomycin, 
procaine penicillin G, dihydrostreptomycin and prednisolone (Tetra Delta, Pharmacia 
and Upjohn Limited Limited, Corby) intramammary tubes, if the cow failed to 
respond or was systemically ill then the local veterinarian was called. The DCT used
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on the farm was framycetin, penethamate hydriodide, procaine penicillin (Leo Red 
Dry Cow, Leo Laboratories Limited, Princes Risborough).
2.3. Reason for investigation
Veterinary investigations were initiated on this farm following notification to the 
farmer by the milk company threatening the possible termination of the milk contract 
due to persistently high BMSCC. The requirements set by the milk company, during 
the study period are summarised in Tables 1 and 2.
Somatic cell count
< 250,000/ml + 0.1 ppl
250,000-400,000/ml NIL
401,000-500,000/ml - 1.0 ppl
> 500,000/ml - 3.0 ppl
Table 1: Somatic cell count (SCC) payment bands, based on three month geometric 
mean.
Hygienic milk quality (TBC)
< 15,000/ml + 0.2 ppl
> 50,000/ml - 2.0 ppl
> 100,000/ml (first occasion) - 5.0 ppl
> 100,000/ml (twice or more within 6 
months)
- 10.0 ppl
Table 2: Hygienic milk quality bands, based on two month arithmetic mean.
2.4. Materials and methods
2.4.1. Historical data
Geometric monthly BMSCC for two years prior to the start o f the investigation, in 
addition to ICSCC which were recorded for all lactating cows on one occasion by the 
local veterinary practitioner, were available. These data were consulted and used for 
planning the approach to the farm investigation.
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2.4.2. Initial farm investigations
A farm visit was arranged in December 1996 to observe the milking routine. The 
ICSCC results from November 1996 were consulted, and cows with ICSCC > 
400,000 cells/ml were selected for further investigation during the farm visit in 
December 1996. Twenty three cows were identified for further investigation on this 
basis. The CMT was used to identify cows with a high SCC on the day o f sampling. 
The CMT was performed on all four quarters of the selected cows. Quarters which 
were positive on CMT were sampled for bacteriological examination.
2.4.2.1. General observations
While on the farm the milking routine and general management o f the dairy were 
assessed. This was important to establish a basis for how best to proceed with the 
investigation. The cows were milked twice daily in a byre using a pipeline system. 
The byre held 10 cows on each side and five different clusters were used.
2.4.2.2. California Mastitis Test
The CMT relies upon a chemical reaction between the CMT reagent, an anionic 
surface active agent or detergent and the nucleic acid of somatic cells to produce a 
gel with bromocresol-violet acting as an indicator (Schalm and Noorlander, 1957; 
Philpot, 1984; Bramley, 1992; Muldoon, 1995; Radostits and others, 1995a). A gel 
is formed when large numbers o f somatic cells are mixed with the CMT reagent 
(Schalm and Noorlander, 1957; Philpot, 1984; Bramley, 1992; Quinn and others, 
1994; Radostits and others, 1994b; Blowey and Edmondson, 1995; Muldoon, 1995).
The cows to be sampled were prepared as for milking, i.e. dirty udders were washed 
with water and dried using paper towels. The technique for CMT as described by 
Schalm and Noorlander (1957), Philpot (1984), Quinn and others (1994), Radostits 
and others (1994b), Blowey and Edmondson (1995) and Muldoon (1995) was 
followed. The first five to ten ml o f milk from each quarter were discarded. An 
equal volume o f quarter milk and the CMT reagent were placed in each o f the four 
wells of the CMT paddles. The paddles were rocked gently for a few seconds and
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observed for any gel formation. Gel formation was considered to be a positive result 
for high somatic cell content in the milk, and those cows were identified for further 
examination.
2.4.2.3. Milk samples
Milk samples were collected from quarters which gave a positive CMT result. 
Sterile glass or disposable plastic containers are considered suitable for sample 
collection (Higgs and Bramley, 1980; Shotts and Leard, 1984; Bramley, 1992; 
Blowey and Edmondson, 1995; Cullor and Tyler, 1996). In order to minimise the 
risk o f contamination of milk samples fastidious attention was paid to teat 
preparation, as described by Higgs and Bramley (1980), Shotts and Leard (1984), 
Watts (1990), Bramley (1992), Blowey and Edmondson (1995), Buswell (1995), 
Muldoon (1995) and Cullor and Tyler (1996). The udders and teats were washed and 
dried using individual paper towels and the teat ends were disinfected with 70% 
alcohol swabs, prior to collection of milk samples. The alcohol was allowed to 
evaporate prior to milk collection. The furthest away teats were cleaned first and the 
nearest teats were cleaned last with the milk samples being collected in the opposite 
order, to reduce the chance o f contamination by the milk collector. The first four to 
six squirts o f milk (approximately 10 ml) were discarded to avoid contamination of 
the milk sample by bacteria from the teat canal. When collecting the milk, the 
container was held as close to horizontal as possible and the lid of the container was 
held face down in the same hand in order to minimise the entry of any contaminants 
and the container was only filled to two thirds o f its capacity. Approximately 10-15 
ml is considered to be an adequate volume from each positive quarter for 
bacteriological culture and sensitivity. In between sampling cows, the sampler 
washed his/her hands with a germicidal solution and, used a new pair o f clean 
disposable gloves for each cow.
2.4.2.3.I. Bacteriological examination
The milk samples were transported directly to the laboratory as recommended by 
Bramley (1992). It is recognised that most bacterial pathogens causing mastitis grow
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on sheep blood agar (Shotts and Leard, 1984; Bramley, 1992; Quinn and others,
1994). Other media commonly used included MacConkey, horse blood and 
chocolate agar medium. The MacConkey agar is used to allow Enterococccus 
faecalis and some gram-negative bacteria to grow (Watts, 1990; Quinn and others,
1994). Horse blood agar is used to culture anaerobic bacteria. The chocolate agar is 
used to aid differentiation of bacteria by means of haemolysins.
The chocolate agar plates were incubated in 50% carbon dioxide and the horse blood 
agar plates were incubated under anaerobic conditions using nitrogen and hydrogen 
gases.
A standard sterile 7mm bacteriological wire loop was used to streak the agar plates, 
as described by Higgs and Bramley (1980), Shotts and Leard (1984), Quinn and 
others (1994), Buswell (1995) and Radostits and others (1995b). The plates were 
incubated at 37°C and examined at 24 and 48 hours after inoculation, as 
recommended by Bushnell (1980), Higgs and Bramley (1980), Shotts and Leard 
(1984), Bramley (1992), Quinn and others (1994), Blowey and Edmondson (1995), 
Buswell (1995) and Radostits and others (1995b). The presence of colonies was 
noted and the colonies were then examined. To identify Streptococcus spp. the 
commercial latex agglutination kit, the API (Analytab Products or bioMerieux) 
system (Quinn and others, 1994) or the CAMP test were used (Bushnell, 1980; 
Shotts and Leard, 1984; Watts, 1990; Cullor and Tyler, 1996). The CAMP test is 
where a S. aureus capable of producing a large zone of partial haemolysis is streaked 
across the centre of blood agar and a colony of Steptococcus spp. is streaked 
perpendicular to the line of staphylococci. The plate is then incubated and examined 
after approximately 24 hours for evidence of a semi-circular or arrowhead shaped 
zone of complete haemolysis in the zone of partial haemolysis, which would be a 
positive result o f the CAMP test indicating that the Streptococcus spp. was S. 
agalactiae (Higgs and Bramley, 1980, Quinn and others, 1994). Gram-stained 
smears of any colonies were examined microscopically, as recommended by Watts 
(1990) and Buswell (1995), to detect whether the organism was gram-positive or 
gram-negative.
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The procedure for testing antibiotic sensitivity has been described by Blowey and 
Edmondson (1995) and their methods were followed in this study. In order to test for 
antibiotic sensitivity, single colonies were taken from the original agar plate and 
added to liquid media, incubated for six to eight hours, and then poured over the 
surface of a second agar plate before small paper discs, impregnated with different 
antibiotics, were placed on the surface o f the plate. This plate was then incubated for 
a further 24 hours. The zone of inhibition around the antibiotic discs were measured 
and compared to a standard as described by Prescott and Baggot (1993). Under 
crude interpretation this means that if  bacterial growth was inhibited around a disc, 
these bacteria were considered to be sensitive to that antibiotic in vitro. However, if 
the bacterial growth reached the edges o f an antibiotic disc, the bacteria were 
considered to be resistant to that antibiotic. The antibiotics tested included 
ampicillin, enrofloxacin, chloramphenicol, lincomycin, oxytetracycline, penicillin, 
streptomycin, trimethoprim/sulphonamide, amoxycillin and clavulanic acid, 
neomycin and cephalexin. The antibiotics for sensitivity were the laboratories 
standard test set.
2.4.2.3.2. Bacterial identification
Staphylococcus aureus colonies tended to be round, white-yellow in colour and 
surrounded by a double zone o f haemolysis on sheep blood agar (Higgs and Bramley, 
1980; Shotts and Leard, 1984; Quinn and others, 1994; Blowey and Edmondson, 
1995; Buswell, 1995). This bacteria did not grow on MacConkey agar. Microscopic 
examination o f a gram-stained smear revealed gram-positive cocci (Higgs and 
Bramley, 1980; Quinn and others, 1994; Blowey and Edmondson, 1995). A 
coagulase test was used to confirm that the isolate was coagulase positive and 
therefore S. aureus (Higgs and Bramley, 1980; Shotts and Leard, 1984; Quinn and 
others, 1994; Buswell, 1995) and a catalase test was used to differentiate 
staphylococci from streptococci and enterococci (Watts, 1990; Quinn and others,
1994).
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Streptococci spp. colonies were small, translucent with a , p or y haemolysis on sheep 
blood agar (Higgs and Bramley, 1980; Shotts and Leard, 1984; Quinn and others, 
1994; Blowey and Edmondson, 1995; Buswell, 1995). a  haemolysis: a zone o f 
greening or o f partial haemolysis. P haemolysis: a clear zone o f haemolysis, y 
haemolysis: no haemolysis (Higgs and Bramley, 1980; Shotts and Leard, 1984). 
Most Streptococci spp. do not grow on MacConkey agar, except some Lancefield 
group D streptococci and E. faecalis (Quinn and others, 1994). The CAMP test was 
used to identify S. agalactiae, which enhanced the partial haemolysis o f S. aureus on 
sheep blood agar (Higgs and Bramley, 1980; Shotts and Leard, 1984; Quinn and 
others, 1994). Streptococci were divided into different groups according to C- 
substance which is a group specific cell wall polysaccharide. Grouping was carried 
out using the API system (Quinn and others, 1994). Microscopic examination o f a 
gram stained smear revealed gram-positive cocci (Blowey and Edmondson, 1995).
2.4.3. Subsequent farm investigation
A second farm visit was arranged in January 1997 in order to collect samples for 
bacteriological examination from cows which had previously given a negative result 
on CMT, and from cows which were identified to have low ICSCC in November 
1996. These cows were selected in order to determine how widespread the mastitis 
infections were even in cows with low ICSCC, and to aid in decision making on how 
best to manage the problem on this farm. Milk samples were collected from all four 
quarters of the selected cows for bacteriological examination, as described in Chapter
2.4.2.3.
2.4.3.1. Bacteriological swabbing
Swabs for bacteriological examination were taken from the cubicles, water troughs, 
surfaces in the byre, udder washing bucket, cluster liners and cow’s udders in order to 
identify possible environmental sources o f udder infection. The swabs were used to 
streak the agar plates and these were incubated and examined as described for the 
milk samples (Chapter 2.4.2.3.1.).
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2.4.4. Data storage and analysis
Data from all phases o f this study were stored in a Microsoft Access (Microsoft 
Corporation) version 2.0 database running on a Viglen Genie PCI Professional 
Microcomputer (486, 266 MHz microcomputer, 1 Gb hard disk).
2.4.4.1. Database design
Microsoft Access (Microsoft Corporation) is a relational database management 
system that allows the storage o f data in related tables. A table is designed by 
naming and specifying the properties offields (columns) which usually relate to one 
piece of information for each cow, such as calving date. Field properties relate to the 
format of data held in the field such as number, text or date. Properties can be 
specified that limit the permissible entries in a field, which can be a useful way of 
reducing errors in data entry. Each cow occupies a single row of the table with an 
entry in all appropriate columns. A key fie ld  (or fields) may be defined to identify 
uniquely each record for the purposes of indexing: in this study the key field was 
defined as the cow identification number. Fields common to two tables may be used 
to relate these tables for the purposes of querying across multiple tables. Single or 
multiple tables can be queried by specifying criteria and writing functions to limit 
and aggregate the data in any desired way. A form shows one complete record on 
screen at a time. As they can be made to follow a logical pattern, forms are a useful 
medium for data entry. Wherever possible, responses were coded to avoid time 
consuming typing and reduce data entry errors. Simple descriptive data analyses 
were carried out by means o f queries. A sample form is presented in Appendix 1.
2.4.4.1.1. Data analysis
Where appropriate, analysis o f variance (ANOVA) and multiple range tests 
(Newman-Keuls) were used to assess the statistical significance of changes in ICSCC 
following implementation of control measures (Pagano and Gauvreau, 1993).
2.4.5. Costings
This study was performed on a commercial farm and it was hoped that the method 
used would be a useful and practical option for veterinary surgeons in general
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practice. The cost o f diagnostic testing and materials used were estimated and 
considered for every part of this project. Time and labour were provided free of 
charge by veterinary researchers and students.
The standard charge for bacteriological examination of a biological sample at the 
University of Glasgow, Department o f Veterinary Bacteriology was £10, irrespective 
of whether it was a milk sample or a bacteriological swab.
The retail value of a one litre container o f CMT reagent was £3.70 and assuming 5 
ml of the reagent was mixed with the same volume of milk this volume would be 
sufficient for 50 cows, it would cost approximately 8p per cow to test all four 
quarters with CMT reagent.
The Scottish Agricultural College in Auchincruive charge 50p per sample for somatic 
cell counting.
2.5. Results
2.5.1. Historical data
The geometric monthly BMSCC for the two years prior to the start o f the 
investigation are summarised in Figure 1. The figure is set out in accordance with 
quota years which ran from the beginning of April to the end of March. These 
monthly BMSCC data are presented in full in Appendix 2.
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Figure 1: Bulk milk somatic cell counts (BMSCC) for two quota years (1995-1996 
and 1996-1997) prior to investigation o f the mastitis problem.
 denotes the maximum BMSCC acceptable under the EC Health and Hygiene
directive 92/46.
It can be seen that the BMSCC was increased above the standard three month 
geometric mean given by EC directive 92/46 o f 400,000 cells/ml from November 
1995 through 1996 to the start o f the study in November 1996. Throughout 1996 the 
BMSCC fluctuated, but was consistently above the maximum acceptable level. In 
December 1996 the BMSCC reached a peak o f 735,000 cells/ml.
Individual cow somatic cell counts recorded in November 1996 are summarised in 
Figure 2.
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Figure 2: Individual cow somatic cell counts (ICSCC) in November 1996.
Thirty nine cows were in milk at the time o f sampling. Twenty three were found to 
have an ICSCC greater than 400,000 cells/ml, 17 had an ICSCC greater than one 
million cells/ml, one cow had an ICSCC greater than 18 million cells/ml and only 16 
cows had an ICSCC less than 400,000 cells/ml. These ICSCC data are presented in 
full in Appendix 3.
2.5.2. Initial farm investigation
2.5.2.I. General observations
In general the buildings were in a poor state o f repair. The cubicle house walls were 
made o f corrugated iron sheets and several o f these were loose and the lying areas 
were covered in faeces. The individual cubicles were approximately 1.8 metres long 
by 1.2 metres wide and the step was very variable but was approximately 20 cm 
high. However, the byre was maintained in good condition and appeared to be 
cleaned regularly.
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Two people were involved in the milking process. Udders which were considered to 
be dirty by the staff were washed using bare hands with warm water from a bucket; 
often the same water was used to wash ten cows’ udders. The water was only 
changed after washing cows on one side o f the byre. The milkers did not clean their 
hands during the milking process. Udders which were washed were subsequently 
dried using disposable paper towels, one for each cow. Foremilking was not carried 
out. Instead udder palpation during the washing procedure was relied upon to detect 
cases of clinical mastitis. Post-milking teat dipping was not practised. There was no 
holding or collecting yard for the cows to gather and the cows were returned to the 
cubicles or field immediately after milking. Routine DCT was not practised, largely 
due to the fact that calving dates were unknown. The length of the dry period was 
very variable and occasional antibiotic failures at bulk milk sampling had been a 
problem in the past.
The cleaning o f the milk line was also unsatisfactory. The cleaning routine after 
milkings differed in the afternoons compared to the mornings. In the mornings, the 
pipeline was cleaned using a cold water rinse, followed by circulation of hot water 
plus detergent followed by a final cold water rinse. In contrast, in the afternoons 
only a cold water rinse was used.
It was advised that hot water should be used to clean the milk line in the afternoon as 
well as in the morning. Ideally the cleaning procedure should consist o f a three 
phase process; hot rinse, wash and sanitise. However, to encourage farmer 
compliance and effect an improvement, it was decided to recommend only a hot 
water wash plus sanitation with sodium hypochlorite.
The liners useage or number o f milkings for each liner, in this 60 cow dairy herd 
which milked twice daily, changed the liners every six months and used five clusters, 
was 4,320 milkings. Recommendations suggest that liners should be changed after 
2,500 milkings or six months, whichever comes first (Blowey and Edmondson, 
1995).
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2.S.2.2. California M astitis Test
O f the 23 cows selected on the basis o f ICSCC o f > 400,000 cells/ml in November 
1996, 15 were positive on CMT in one or more quarters. Twenty six quarters from 
the 15 cows were CMT positive. Four o f the cows selected were found to be CMT 
negative in all four quarters. The remaining four cows which had ICSCC > 400,000 
cells/ml in November 1996, were dry at the time o f sampling in December 1996 and 
were, therefore, not available for CMT. The results o f the CMT are summarised in 
Figure 3.
1 6 - i
Figure 3: California Mastitis Test (CMT) results from the 23 selected cows.
2.5.2.3. Bacteriological examination
Streptococcus agalactiae was the most common bacterial pathogen isolated from 
CMT positive quarters, it was isolated from eight cows in total. Staphylococcus 
aureus was isolated from five cows in total. A mixed S. agalactiae and S. aureus 
infection was identified in two cows. Other bacteria isolated from these cows, and 
the other four CMT positive cows included Staphylococcus epidermidis,
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Corynebacterium spp., Bacillus spp. and A. pyogenes. Only one CMT positive cow 
had no bacteria detected in the milk sample taken. Figure 4 shows the number o f 
cows infected with each bacterial isolate.
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Figure 4: Bacteria isolated from California Mastitis Test (CMT) positive cows. 
*Miscellaneous bacteria were S. epidermidis, Corynebacterium spp., Bacillus spp. 
and A. pyogenes.
From the 15 CMT positive cows, 26 quarters were CMT positive and were sampled 
for bacterial culture and sensitivity. Streptococcus agalactiae infection was found in 
14 quarters, S.aureus in six quarters, mixed S. aureus and S. agalactiae infection in 
three quarters, and various combinations o f the miscellaneous bacteria listed above 
were isolated from nine quarters. In only one CMT positive quarter were no bacteria 
detected in the milk sample. Figure 5 shows the number o f quarters infected with 
each bacterial isolate.
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Figure 5: Bacteria isolated from California Mastitis Test (CMT) positive quarters. 
*Miscellaneous bacteria were S. epidermidis, Corynebacterium spp., Bacillus spp. 
and A. pyogenes.
Antibiotic sensitivities showed that S. aureus and S. agalactiae isolated from this 
herd were sensitive to most antibiotics. Table 3 summarises the antibiotic 
sensitivities o f the bacteria isolated.
59
Antibiotics S. aureus S. agalactiae
ampicillin some resistance sensitive
enrofloxacin sensitive sensitive
chloramphenicol sensitive sensitive
lincomycin sensitive sensitive
oxytetracycline some resistance sensitive
penicillin some resistance sensitive
streptomycin resistant resistant
amoxycillin/clavulanic acid sensitive sensitive
trimethoprim/ sulphonamide sensitive some resistance
cephalexin sensitive sensitive
neomycin sensitive some resistance
Table 3: Antibiotic sensitivities for Streptococcus agalactiae and Staphylococcus 
aureus from the study herd.
From these results, S. aureus and S. agalactiae from this herd were considered to be 
sensitive to enrofloxacin, chloramphenicol, lincomycin, amoxycillin/clavulanic acid 
and cephalexin in vitro.
2.5.3. Subsequent farm investigation
Two of the cows which were CMT negative at the previous visit had been dried off 
by January 1997 and so were unavailable for sampling. This left only two CMT 
negative cows and the four low SCC cows available for sampling. All six cows were 
found to have S. agalactiae infection in one or more quarters, and four o f them also 
had S. aureus infection. At the quarter level, six quarters had S. agalactiae infection 
and four quarters had S. aureus infection. In these, and other, quarters from the six 
cows, miscellaneous bacteria were also isolated and included S. epidermidis, A. bovis 
and Bacillus spp. No bacteria were isolated from only seven quarters of these six 
cows.
Bacillus spp. were cultured from swabs taken from the cubicles, water troughs, 
surfaces in the byre, udder washing bucket and the udder. Streptococcus agalactiae 
was isolated from a swab taken from one of the cluster liners. No other mastitis 
pathogens were detected from the environmental samples.
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2.5.4. Costings
The costs involved in the investigation o f the high BMSCC in this herd were the cost 
of the CMT and the cost of bacteriological examination of milk samples from 
quarters which were positive on CMT. The cost of the ICSCC, which were carried 
out by the local veterinary practitioner were included.
Nineteen cows were available for CMT, and 15 were positive, giving a total o f 26 
quarters which were sampled for bacteriological examination. On the second farm 
visit, all four quarters o f six cows was sampled for bacteriological examination and 
six swabs were taken from the environment. Therefore, the cost of CMT was £1.52 
and the cost of the bacteriological examinations were £560. The ICSCC for 39 cows 
cost £19.50. Giving a total cost o f investigations of £581. Table 4 details the costs 
o f the investigation.
Analysis Type of sample No. of 
sample
s
Cost of 
analysis
Calculation Total
ICSCC Composite from all 
lactating cows in 
November 1996
39 5 Op per 
sample
39 x 0.5 £19.50
CMT All quarters from 
selected cows
19 8p per cow 19x0.08 £1.52
Bacteriology Quarter samples 
from CMT positive 
quarters
26 £10 per 
sample
1 0 x 2 6 £260
Bacteriology Quarter samples 
from all cows 
sampled on second 
farm visit
24 £10 per 
sample
1 0 x 2 4 £240
Bacteriology Swabs from 
environment
6 £10 per 
sample
1 0 x 6 £60
TOTA1.C O S T £581
Table 4: Costs o f initial investigation o f the herd
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2.6. Discussion
Farm production data were limited, meaning that it was difficult to assess the extent 
o f the mastitis problem on this farm. However, historical data for BMSCC were 
available for two years prior to the investigation of this problem. From these data it 
could be seen that the BMSCC of this herd had been above the EC standard of
400,000 cells/ml from November 1995, and remained consistently high until the start 
of this investigation in November 1996. The samples collected in November 1996 
showed that 23 o f the 39 cows lactating at that time had ICSCC > 400,000 cells/ml. 
The BMSCC and ICSCC provided sufficient information to identify that this farm 
had a chronic widespread mastitis problem.
Following the farm visit, an impression o f the management and hygiene on the farm 
was made. The cubicles were too small for the cows and the hygiene was poor due to 
the lack of bedding and attention to detail. The recommended size o f cubicles for 
modem dairy cows is 2.3-2.4 metres long by 1.2 wide (Blowey and Edmondson,
1995) and the International Dairy Federation (IDF) (Anon, 1987) states that short 
stalls can increase the incidence of udder disease and that bedding material should be 
used to provide a clean, dry area for the cows to lie.
It was found that the milking routine and teat preparation were inadequate in relation 
to the standard recommendations outlined in the ‘Five Point Plan’ (Philpot, 1984; 
Bramley, 1992; Biggs, 1996). The washing of the udders from a communal bucket 
acted as a potential medium for spread o f infection between cows. The hands of the 
staff acted as an additional potential source of contamination (Bushnell, 1984; 
McDonald, 1984; Fox and Gay, 1993; Radostits and others, 1994a; Rebhun, 1995; 
Cullor and Tyler, 1996). No foremilking was performed, potentially allowing 
mastitic milk to enter the bulk tank. Post-milking teat dipping and dry cow therapy 
were not carried out as a routine, meaning that control and elimination o f mastitis 
pathogens was also likely to be very poor.
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The poor cleaning o f the milk line may have contributed to the overall problem on 
this farm. The cleaning routine used was unlikely to be sufficient, as cold water 
congeals any residual butterfat in the system, thus making it more difficult to remove 
during the cleaning process (Guterbock and others, 1984). The IDF states that for 
circulation cleaning, as used on this farm, the water temperature should reach a 
minimum of 85°C (Anon, 1987). It is known that poor sanitation increases the 
number of bacteria colonising the pipelines (Guterbock and others, 1984).
The liners were not changed frequently enough. Recommendations suggest that 
liners should be changed after 2,500 milkings or six months, whichever comes first 
(Blowey and Edmondson, 1995). Worn liners can cause damage to the teats and can 
also become more difficult to clean (Blowey and Edmondson, 1995).
The lack o f treatment records and the absence of facilities to measure individual cow 
milk yields meant that it was difficult to assess whether the high BMSCC was due to 
a small number of cows or whether it was likely to be a herd problem, as a high 
BMSCC could result from a small number o f cows with high ICSCCs (Dohoo and 
Meek, 1982). Alternatively, the high BMSCC may have been due to a high 
proportion of cows being in late lactation or having calved recently (Chapter 1.4.2.). 
The expected calving dates were not known on this farm. For this reason, efficient 
drying off could not be performed. The dry periods would have been of a variable 
length and antibiotic residues in milk due to inappropriate DCT would have been 
likely.
Milk sampling undertaken in December 1996 revealed 14 out of the 21 cows sampled 
(66.6%) to have S . agalactiae infection and nine cows (42.9%) to have S. aureus 
infection. Six cows (28.6%) had both infections. The use of the CMT, along with the 
ICSCC, was an easy, inexpensive method to determine the best cows to select for 
further investigations. This method, described by Logue (1997), has been shown to 
improve the efficiency o f bacteriological examination of milk samples. In this study, 
only one milk sample, from one udder quarter, was found to be sterile on bacterial 
culture. The isolation o f S. agalactiae from a cluster liner suggested that this species
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of bacteria may persist in the environment for a long enough period to act as a 
potential source for the spread of infection within herds, in contrast to published 
results of others (McDonald, 1977; Biggs, 1996; Cullor and Tyler, 1996).
The antibiotic sensitivities showed that the S. aureus isolated from this farm were, in 
general, resistant to the (3-lactam penicillins as would be expected from previous 
reports (Sandholm and others, 1990; McKellar, 1991; Vestweber and Leipold, 1993) 
and also because the farmer was likely to have poor antibiotic management judging 
by the geaneral farm management and record keeping. The S. agalactiae isolated 
from this farm were sensitive to most antibiotics with activity against gram-positive 
organisms, again as would be expected (Prescott and Baggot, 1993).
The cost of investigations, which did not include professional time or farm labour, 
amounted to £281. Fetrow (1980) reported that farmers are often unaware o f the 
costs of subclinical mastitis and this proved to be true in this farm. The farmer 
considered the costs o f the investigations too high to be cost-effective.
Taking into consideration historical farm data and the results of farm investigations, 
this farm was found to have a major contagious mastitis problem. At the time of 
sampling, imminent legislation changes, penalties imposed by the milk purchasers, 
lost milk yield and poor cow welfare demanded that immediate action was taken to 
rectify the situation in order to prevent the farm going out of business.
The first step was to implement improvements in the milking routine, with specific 
mastitis therapy for the herd being considered depending on the uptake of these 
changes. It was decided that the milking routine should be improved in the first 
instance in order to assure, as far as possible, the success o f any subsequent control 
measures.
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The recommended improvements included:
1. A pipeline for running water should be installed to reach the byre, with a hose 
attachments fitted, and this is to be used for washing the udders.
2. The washed udders should continue to be dried using individual paper towels for 
each cow.
3. A strip cup should be used for foremilking to aid in the diagnosis o f clinical 
mastitis.
4. The clusters should be disinfected between milking either side o f the byre, when 
the clusters fall off the cow during the milking process, and especially after 
milking a mastitic cow.
5. Post-milking teat dipping should be carried out after each milking using an iodine 
based preparation.
6. The cleaning o f the milk line should be improved, such that the routine should 
consist of washing with hot water and sodium hypochlorite and then a cold rinse 
for both the morning and evening milkings.
7. Herd records should be improved; service and calving dates, cases of mastitis and 
treatments administered should be recorded. Charts were given to the farmer to 
enable the calving dates to be calculated from the service dates and recording 
sheets were given to aid in the recording of service dates, calving dates and any 
mastitis cases and the treatments administered. Samples of these forms are 
presented in Appendices 4 and 5, respectively.
Interpretation o f the results suggested that the high BMSCC was largely caused by 
infection with S. agalactiae and S. aureus, with other pathogens playing a minor role. 
Due to the imminent financial problems facing the farmer, a rapid reduction in SCC 
was thought to be essential. Following discussion with clinicians, bacteriologists, 
pharmacologists and epidemiologists (Dr. J. Fitzpatrick, Dr. D. Taylor, Professor Q. 
McKellar, Dr. D. Mellor, Mr T. King and Mr D. Barrett), the decision was made to 
treat this herd. Consultation o f the literature in combination with the knowledge of 
this expert panel suggested that ‘blitz therapy’ had been a successful method for 
eliminating S. agalactiae from infected herds (Biggs, 1996; Cullor and Tyler, 1996). 
With this in mind, and considering the likely relative merits of partial and whole herd
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programmes (Chapter 1.9.2.) on this farm, it was decided to opt for a whole herd 
‘blitz therapy’. The considerations, drug choices, implementation and results o f the 
whole herd ‘blitz therapy’ are presented in Chapter 3. It was recognised that the 
presence o f S. aureus infection would be a complication in the successful reduction 
o f the BMSCC of this herd.
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Chapter 3 
Whole herd ‘blitz therapy’
3.1. Introduction
‘Blitz therapy’ is the simultaneous treatment o f all four quarters of the cows udder 
with intramammary infection, or all cows in a herd where a high prevalence of 
intramammary infection has been identified (Roberts and others, 1969; Erskine and 
Eberhart, 1990; Blowey and Edmondson, 1995; Biggs, 1996) and usually relates to 
treatment with intramammary preparations (Blowey and Edmondson, 1995). This 
programmed treatment with antibiotics is aimed specifically at eradicating S. 
agalactiae infection from a herd (Weaver and others, 1986; Erskine and Eberhart, 
1990; Blowey and Edmondson, 1995; Biggs, 1996). Whole herd treatment is 
recommended if the infection has a high prevalence within the herd, if  the infection 
has been present for years as indicated by a prolonged high BMSCC, or if  a large 
proportion o f the cows are in milk at the time o f instigation of the regime (Biggs,
1996). The whole herd approach is simple to carry out and produces more 
predictable results than the partial herd approach, although there are greater initial 
costs involved in treating and discarding milk from all cows (Biggs, 1996). In 
contrast, the partial herd approach involves more commitment on the farmers’ behalf, 
with repeated herd screening being necessary (Biggs, 1996).
Intramammary administration is considered an adequate route for treatment against S. 
agalactiae infection (Prescott and Baggot, 1993; Blowey and Edmondson, 1995). 
However, the intracellular nature of S. aureus infection means that the intramammary 
route may not be effective due to poor distribution o f the drug into abscesses, or poor 
uptake into the relevant cellular compartments (Craven and Anderson, 1979; Ziv, 
1980; Madgwick and others, 1989; Sandholm and others, 1990; Bramley, 1992;
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Blowey and Edmondson, 1995). Parenteral administration with an appropriate 
antibiotic should achieve better udder distribution and penetration than 
intramammary administration (Prescott and Baggot, 1993), depending on lipid 
solubility, degree of ionisation and the extent of protein binding of the drug molecule 
(Ziv, 1980; Sandholm and others, 1990). Owens and others (1988) reported that 
intramammary infusion coupled with parenteral treatment was a superior method for 
treating subclinical mastitis during lactation, compared to using only intramammary 
treatments.
There are a vast selection o f antibiotics licensed for the treatment o f mastitis in cattle 
(Anon, 1998). Both the major bacteria isolated from cows on this farm were gram- 
positive organisms, therefore, drugs with good efficacy against this type of bacteria 
were considered for possible use in the treatment of this herd.
The drug o f choice for the elimination of S. agalactiae infection is penicillin 
(Bushnell, 1980; Sandholm and others, 1990; McKellar, 1991), which is bactericidal 
in action. However, penicillin is less effective against S. aureus because many 
strains of this organism produce p-lactamase which renders them resistant to 
penicillin (Sandholm and others, 1990; Blowey and Edmondson, 1995). 
Amoxycillin is a broad spectrum penicillin derivative with a better action against S. 
aureus than penicillin (Blowey and Edmondson, 1995). Clavulanic acid is a 
synthetic drug which brings about the irreversible inhibition of p-lactamase 
(Sandholm and others, 1990; McKellar, 1991). It is combined in commercial 
preparations with amoxycillin to produce a drug with a broad spectrum of activity 
and good action against P-lactamase producing S. aureus (Sandholm and others, 
1990; McKellar, 1991; Blowey and Edmondson, 1995). Cloxacillin and nafcillin are 
potentiated penicillins with even better activity than amoxycillin against S. aureus 
and they are also effective against P-lactamase producing strains (McKellar, 1991; 
Blowey and Edmondson, 1995). However, cloxacillin, nafcillin and amoxycillin are 
not as efficacious as penicillin against S. agalactiae (Sandholm and others, 1990; 
McKellar, 1991).
68
Cephalosporins are semi-synthetic, bactericidal antibiotics with good activity against 
gram-positive bacteria, though less so than penicillins, and all are resistant to P- 
lactamase (McKellar, 1991; Blowey and Edmondson, 1995). There are no milk 
withdrawal period for some preparations o f cephalosporins, but they are relatively 
expensive compared to alternative antibiotics.
Macrolides are bacteriostatic antibiotics with good tissue distribution, high 
intracellular concentrations and activity against gram-positive bacteria and 
Mycoplasma spp.. Erythromycin is a macrolide with good activity against S. aureus 
(McKellar, 1991; Blowey and Edmondson, 1995) but, unfortunately, only 
intramammary preparations are currently available in the UK for use in cattle (Anon, 
1998). Tylosin is a macrolide antibiotic licensed for use in cattle and again is only 
available as a parenteral preparation (Anon, 1998). Unfortunately, most other 
macrolides given systemically have long milk withdrawal periods making them 
unsuitable for use in lactating cows.
The bacteriostatic antibiotics rely on the cow’s own defence mechanisms to 
overcome infection whereas, bactericidal antibiotics kill the bacteria. Therefore, in 
sick cows bactericidal antibiotics may be preferred. However, the sudden bacterial 
death may release endotoxins which may make the cow’s condition worse (Blowey 
and Edmondson, 1995).
A sixty cow dairy herd was found to have a high prevalence of S. agalactiae and S. 
aureus infections (Chapter 2). Streptococcus agalactiae was present in 66.6 % of a 
pre-selected sample population, and as elimination of this pathogen is possible 
(McDonald, 1977; Edmondson, 1989; Blowey and Edmonson, 1995; Biggs, 1996), it 
was decided to start by tackling the S. agalactiae infection. Treatment to eradicate S. 
agalactiae infection from the herd was anticipated to bring about a rapid reduction in 
BMSCC, as shown by Erskine and Eberhart (1990).
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3.2. Materials and methods
3.2.1. Therapeutic regimes
Various regimes for the herd in this study were considered and these included:
1. ‘Blitz’ treatment of all cows against S. agalactiae.
2. ‘Blitz’ treatment of cows known to be infected with S. agalactiae.
3. ‘Blitz’ treatment of all cows against S. agalactiae and S. aureus.
4. ‘Blitz’ treatment of cows known to be infected with S. agalactiae or S. aureus.
5. Any of the regimes 1-4 plus parenteral treatment for S. aureus.
6. Any of the regimes 1-4 plus culling of the cows infected with S. aureus.
The farm economics and the high percentage o f cows infected with S. aureus made 
culling on the basis o f S. aureus infection impractical. After considering the high 
prevalence o f infection and the chronic nature o f the problem within the herd, as well 
as the ease o f management and the more predictable results from whole herd 
treatment, a whole herd approach was adopted as described by Biggs (1996). The 
decision to combat the S. agalactiae problem using a whole herd ‘blitz therapy’ with 
parenteral and intramammary treatment was made after consultation with an expert 
panel (Chapter 2.10.2). In this herd, the combined use o f intramammary and 
parenteral preparations was chosen to ensure optimal tissue penetration and 
distribution in order to combat intramammary infection. In this project, although the 
‘blitz therapy’ was aimed primarliy at eradicating S. agalactiae from the herd, it was 
hoped that a reduction in the level of S. aureus infection might also be achieved.
3.2.2. Antibiotic options
Antibiotics were considered in relation to their action against both S. agalactiae and 
S. aureus. In this study, subclinical mastitis was the major problem and therefore the 
choice between bactericidal and bacteriostatic antibiotics was not crucial.
After considering the activity, the cost, and the milk withdrawal periods of the drugs, 
the ideal treatment was considered to be nafcillin or cloxacillin by parenteral 
administration and penicillin by intramammary infusion. This would have action
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against S. agalactiae (penicillin) and S. aureus (nafcillin or cloxacillin). 
Unfortunately, there were no preparations available containing cloxacillin or nafcillin 
for parenteral administration (Anon, 1998), therefore, it was decided to use penicillin 
by the parenteral route in addition to nafcillin by intramammary infusions. Nafcillin 
was chosen as the intramammary drug treatment for the lactating cows because of its 
action against S. aureus, and penicillin was chosen as the parenteral treatment for its 
known efficacy against S. agalactiae (Murphy and Stuart, 1954).
The dry cows were also to be treated, as S. aureus and S. agalactiae are known to 
persist during the dry period (Dodd and Griffin, 1975; Philpot, 1975; Philpot, 1984). 
Parenteral treatment was chosen, and again the aim was to combat both S. agalactiae 
and S. aureus infections if  possible. As the calving dates were unknown for many of 
the cows, intramammary DCT could not be used because the long milk withdrawal 
period of those drugs might have resulted in drug persistence after calving, thus 
requiring milk to be discarded for an extended period in early lactation. Parenteral 
amoxycillin combined with clavulanic acid was the treatment chosen for the dry 
cows.
3.2.3. Implementation
A total herd ‘blitz’ regime was chosen rather than partial ‘blitz therapy’, mainly due 
to the widespread nature of the infection in this herd and because this routine was 
simpler for the farmer to follow.
The milking cows, including heifers, and the dry cows were given a three day course 
of treatment. The treatments were administered immediately after the morning 
milkings. The teats were prepared as for milk sampling (Chapter 2.4.2.3.) prior to 
infusion of the intramammary antibiotics, and after the infusions, post-milking teat 
disinfection was undertaken.
The lactating cows were given procaine penicillin (Depocillin, Intervet UK Limited, 
Cambridge) by intramuscular injection, and nafcillin, dihydrostreptomycin and 
sodium benzylpenicillin (Nafpenzal MC, Intervet UK Limited, Cambridge) by 
intramammary infusion once daily for three days.
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The dry cows were given amoxycillin and clavulanic acid (Synulox, Pfizer Ltd, 
Sandwich) by intramuscular injection once daily for three days.
The antibiotics were administered by veterinary researchers and students, as it was 
felt that the farmer could not be relied on to identify the cows correctly and 
administer the appropriate treatment.
Following treatment on the third day, the byre was disinfected and the liners o f every 
cluster were discarded and replaced with new, unused liners. The old liners were 
removed from the farm for disposal. The cubicles were cleaned and fresh sawdust 
put down. The farmer was instructed to maintain the herd as a closed herd, and only 
to buy uncalved heifers as replacements if  suitable homebred animals were 
unavailable.
3.2.4. Logistical considerations
Milk was discarded for the recommended statutory withdrawal period for the drugs 
used. The milk purchasing company were informed of the treatment, and undertook 
to check the bulk milk prior to collection after this period in order to ensure that no 
antibiotic residues were present in the milk. The farmer was instructed to withhold 
the milk, from the bulk tank, from any dry cow calving within a week after the ‘blitz 
therapy’, for one further week after the usual withdrawal period.
3.2.5. Costings
To calculate the cost o f the ‘blitz therapy’, the loss in income due to discarding milk 
during the treatment period had to be considered along with the cost of the 
antibiotics. No costs were calculated for the visits or professional time.
Inspection of data from National Mastitis Council (Anon, 1998) showed that the 
average cow produces approximately 5,790 litres o f milk per lactation. However, it 
was considered unlikely that the cows in the study herd would be achieving an 
average daily yield o f 19 litres. And after considering the milk returns (Appendix 8), 
and considering wastage and milk for calves, it was estimated that the average yield
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per lactation o f a cow in this herd was 2500-3000 litres. The herd was assumed to 
calve all year round with each cow having an average lactation of ten months, 
therefore, giving the daily yield per cow as 10 litres/day.
The average price paid for milk in 1997 by milk purchasing companies was 22 pence 
per litre (ppl) (Anon, 1998). However, prior to the ‘blitz therapy’ the high BMSCC 
resulted in the imposition o f a penalty o f three pence per litre of milk produced. The 
penalty was a standard penalty imposed by the milk purchasing company on milk 
with BMSCC > 500,000 cells/ml. Therefore, the farmer received 19 ppl rather than 
the average 22 ppl, prior to the ‘blitz therapy’.
3.3. Results
3.3.1. ‘Blitz therapy’
Forty three cows were lactating at the time of the ‘blitz therapy’ and were given 
treatment with procaine penicillin (Depocillin, Intervet UK Limited, Cambridge) by 
intramuscular injection and nafcillin, dihydrostreptomycin and sodium 
benzylpenicillin (Nafpenzal MC, Intervet UK Limited, Cambridge) intramammary 
tubes, once daily for three days. Twelve cows were dry at the time of the ‘blitz 
therapy’ and were given intramuscular amoxycillin combined with clavulanic acid 
(Synulox, Pfizer Ltd, Sandwich), once daily for three days. One cow calved on the 
third day of the treatments. This animal was given amoxycillin combined with 
clavulanic acid (Synulox, Pfizer Ltd, Sandwich) on the first day of the ‘blitz’ and was 
then noticed to be close to calving and was subsequently separated from the herd. 
Following calving, the cow was treated with the same drug regime as was 
administered to the lactating cows during the ‘blitz’; the cow was returned to the herd 
after the statutory milk withdrawal period. A milk sample was collected and 
analysed for antibiotic residues to ensure that the milk was safe to enter the bulk 
tank. The treatments administered to each cow are detailed in Appendix 6.
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3.3.2. Problems encountered during the treatment
The ‘blitz therapy’ began on 18th March 1997 and the replacement o f the liners, the 
byre disinfection and the bedding of the cubicles occurred on 20th March 1997. The 
longest withdrawal period for the antibiotics was three and a half days, however, 
when parenteral and intramammary treatments are used in conjunction the standard 
seven day milk withdrawal should be applied as the intramammary tubes used are not 
licensed for use along with parenteral antibiotics. Therefore, the milk would be able
tilto be sold for human consumption from the 25 March 1997. The milk company 
was notified about the herd treatment and were monitoring the bulk tank for 
antibiotic residues prior to collection. Antibiotic residues were present in the bulk 
tank milk on 24th March 1997, but on the 25th March 1997 the bulk tank milk was 
free from antibiotic residues and could be collected for sale as was planned. 
Therefore, the total milk yield from this herd was discarded for one week.
One cow calved within one week of the ‘blitz therapy’, calving on 23rd March 1997 
and her milk was withheld for one further week in order to ensure that no antibiotic 
residues resulted from the combined use of parenteral antibiotics with DCT. 
However, there were no records detailing when, or if, this cow was ever given DCT.
3.3.3. Costings
There were 44 cows (including the recently calved cow) in milk at the time o f the 
treatment, and milk was discarded for seven days. The total volume o f milk 
discarded was estimated to be 10 x 7 x 44 = 3,078 litres. With the penalties being 
accounted for, the farmer was receiving 19 ppl. The total cost of the discarded milk 
was therefore 3,078 x 0.19 = £585.
The cost of the treatment of the herd included only the costs o f the drugs. The 
intramammary infusions for the lactating cows cost £602 for the three day period, 
with the parenteral treatment for these animals for the same period costing £134. The 
parenteral antibiotics administered to the dry cows for the three days cost £121. 
These figures were the cost price direct from the drug wholesalers and, as most 
veterinary practices have a 50% mark up charge on all drug sales (SPVS fee survey
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1997), this gave an estimated total cost for the ‘blitz therapy’ of £1,388. The cost of 
antibiotics used for the ‘blitz therapy’ are detailed in Table 5.
The whole herd ‘blitz therapy’ cost the farmer £1973, this included the cost o f the 
drugs and the loss in revenue due to the milk being discarded for one week.
Antibiotic Volume/quantity 
of antibiotic used 
per cow
No. of 
cows
Total 
quantity of 
antibiotic 
used
Cost of 
antibiotic
Total
Nafpenzal 4 tubes 44 4 x 44 x 3 = 
528 tubes
£22.80 for 
20 tubes
£602
Depocillin 20 ml 44 20 x 44 x 3 = 
2640 ml
£5.06 for 
100 ml
£134
Synulox 25 ml 12 25 x 12 x 3 = 
900 ml
£20.99 for 
100 ml
£189
Total cost of ‘blitz therapy’ £925
with 50% mark up £1388
Table 5: Costs o f the ‘blitz therapy’ treatments
3.4. Discussion
The whole herd ‘blitz therapy’ regime was selected for this herd rather than the 
partial herd approach because the S. agalactiae infection was chronic and 
widespread: 77% of the herd were lactating at the time when treatment was being 
considered, and it was thought that the farmer could not be relied on to follow the 
treatment protocol necessary for the partial herd treatment. The high prevalence o f S. 
aureus infection in the herd meant that antibiotics were chosen for the ‘blitz therapy’ 
which had a good activity against S. agalactiae and S. aureus. Nafcillin was selected 
as the intramammary treatment for the lactating cows because of its action against S. 
aureus (McKellar, 1991) and penicillin was chosen as the parenteral treatment for its 
known efficacy against S. agalactiae (Sandholm and others, 1990; McKellar, 1991). 
The treatment for the dry cows was chosen with the intention that it should eliminate
S. agalactiae and reduce S. aureus, therefore, parenteral amoxycillin combined with 
clavulanic acid was chosen.
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Whole herd ‘blitz therapy’ was carried out on the 56 cows in the herd, 43 were 
lactating, one was recently calved and 12 were dry at the time of the ‘blitz therapy’. 
Unfortunately DCT could not be carried out in this herd because expected calving 
dates were unknown and, as a result, safe milk withdrawal periods could not be 
calculated. The direct cost o f ‘blitz therapy’ was £1,973, labour costs were not 
included.
It was planned to monitor the herd closely for one year in order to check that 
infection did not recur. The procedure adopted and results of monitoring the herd are 
presented and discussed in Chapter 4.
Chapter 4
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Monitoring
4.1. Introduction
Somatic cell counts may be used to estimate the degree of inflammation within the 
udder of a cow and hence the presence o f mastitis (Dohoo and Meek, 1982; Booth, 
1985; Sears and others, 1993; Cullor and Tyler, 1996). Therefore, BMSCC will 
provide a crude indication of the mastitis status of a herd (Westgarth, 1975; Booth, 
1996; Logue, 1997). Consequently, it is the BMSCC, along with the TBC of a 
sample of bulk milk that is the basis o f the legislation governing the quality of milk 
at the farm gate level. The European Community Health and Hygiene Directive 
92/46 requires bulk milk to have a SCC < 400,000 cells/ml and a TBC < 100,000 
cells/ml (Chapter 1.3.).
Since BMSCC acts as an indicator for the level o f subclinical mastitis in a herd it is a 
cheap, convenient method for monitoring the response to any control measures or 
management changes and for monitoring the mastitis status o f a herd. BMSCC are 
measured weekly by the milk company and payments are made based on three month 
geometric means. Milk companies impose price penalties for high BMSCC (Chapter
2.3.). Measurement of somatic cells are performed in the UK by automated 
Fossomatic counters (Blowey and Edmondson, 1995).
Another method used for monitoring the herd status is bulk milk bacteriology, which 
is a simple, specific, but insensitive method of monitoring the herd for the presence 
of bacteria in the milk (Godkin and Leslie, 1991; Lawrence, 1997) and is useful as a 
post-treatment check (Biggs, 1996). However, both these techniques, BMSCC and 
bacteriological examination of bulk milk, are more accurate for monitoring 
contagious pathogens as these tend to be shed in higher numbers than environmental
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pathogens (Neave, 1975).
Somatic cell counts and bacteriological sampling at the individual cow and 
individual quarter level are more precise methods than at the bulk milk level for 
detecting the disease status o f individual cows. Furthermore, data from quarter 
samples will provide the most accurate assessment o f the prevalence of infection in 
the herd, as individual quarter SCC will not be affected by the dilution o f low SCC 
milk from non-infected quarters o f the same cow in an ICSCC or o f all cows in a 
BMSCC (Reneau, 1986). However, the increased number of samples required for 
monitoring by such means increases the financial and time costs involved.
4.2. Materials and methods
In order to monitor the response to whole herd ‘blitz’ treatment in the study herd, a 
number of sampling techniques were used.
4.2.1. Bulk tank screening
At the bulk tank level, samples were collected for bacteriological examination 
weekly for the first 12 weeks after the blitz treatment, and monthly thereafter for nine 
months. Bulk milk SCC were monitored weekly for one year after the ‘blitz’ 
treatment. The milk company kindly forwarded the BMSCC to the veterinary school 
every week.
4.2.2. Herd screening
Herd screening was also performed to monitor the SCC and bacteriological status of 
the individual lactating cows. This also provided the ideal opportunity to monitor the
S. aureus status o f the herd. Initially, it was decided to carry out the herd screenings 
one month ‘post-blitz’ and then six months later to monitor the possible return of S. 
agalactiae infection. Two additional herd screenings were performed to follow the 
progression of the S. aureus infected cows. Therefore, for the November and January 
herd screenings, cows which were infected with S. aureus were targeted for further 
sampling.
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Two 10 ml milk samples were collected from each quarter using sterile technique 
(Chapter 2.4.2.3.) from all the lactating cows on two different occasions, and from 
cows which were found to have S. aureus infection on two further occasions, over a 
one year period after the ‘blitz’ treatment. On each occasion, one sample was 
submitted for SCC and one for bacteriological culture.
Composite samples, made up o f equal volumes o f milk from all four quarters o f one 
cow, were collected for bacteriological examination at the October herd screening 
due to technical difficulties. This reduced the accuracy of the herd screening on this 
one particular occasion, with the possibility of bacterial overgrowth from one quarter 
obscuring the presence o f some pathogens from other quarters, and thereby an 
infected cow may have gone undetected.
4.2.3. Costings
4.2.3.1. Cost of monitoring
Costs involved in monitoring the herd for S. agalactiae and S. aureus infection 
included the cost o f bacteriological examination of weekly, then monthly, bulk milk 
samples; the cost o f bacteriological examination of individual quarter or individual 
cow milk samples; and the cost of IQSCC of all lactating cows during the herd 
screenings. The cost o f somatic cell counting is 50 pence per sample, therefore, it 
costs £2 per cow.
4.2.3.2. Effects of somatic cell counts on production
Assuming an average reduction of 10% in milk yield for the cows in this study 
during the period when the BMSCC were increased above the EC standard, and 
assuming an average daily milk yield o f 10 litres, a high SCC cow in this herd would 
produce 19.8 litres/day. The farmer could potentially lose an average of 22p daily 
for each cow with a high SCC, and calculated on a herd basis lose £11 each day if the 
cows had an increased SCC (calculations assume a ten month lactation, an even year 
round calving pattern, therefore meaning that approximately of 50 cows will be in 
milk at any one time, and a milk price o f 22 ppl, with a three ppl deduction for high
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BMSCCs).
4.3. Results
4.3.1. Bulk tank screening
4.3.1.1. Bacteriology
Over the one year period o f monitoring the herd after ‘blitz therapy’ there was no 
evidence o f S. agalactiae infection from the bulk milk samples at any time. 
However, some species of bacteria were detected in most of the milk samples 
collected, although in most cases, the bacteria isolated were considered to be non- 
pathogenic. Staphylococcus aureus was identified in 10 of the 22 bulk milk samples 
collected though these 10 samples were not consecutive samples. Staphylococcus 
aureus was consistently isolated from the last four bulk milk samples. Table 6 
summarises the bacteriology results from the bulk milk samples.
Month
sample
taken
Date Period 
following ‘blitz 
therapy’
Bacteria isolated
1 Mar-97 19 2 days none
2 27 1 week Staphylococcus aureus
3 Apr-97 4 2 weeks Staphylococcus aureus, Gemella 
morillorum, Staphylococcus spp. and 
Bacillus spp.
4 17 3 weeks none
5 23 4 weeks Staphylococcus aureus
6 May-97 1 5 weeks Aeromonas sp.
7 7 6 weeks none
8 13 7 weeks Staphylococcus epidermidis
Table 6: Bacteriology results from weekly and monthly bulk milk samples taken 
during the one year monitoring period following ‘blitz therapy’.
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9 May-97 21 8 weeks Staphylococcus scuiri
10 29 9 weeks Pseudomonas cepacia
11 Jun-97 4 10 weeks Staphylococcus aureus
12 13 11 weeks Streptococcus spp.
13 21 12 weeks none
14 Jul-97 18 4 months Staphylococcus aureus
15 Aug-97 18 5 months Staphylococcus spp.
16 Sept-97 19 6 months none
17 Oct-97 16 7 months Staphylococcus aureus
18 Nov-97 19 8 months Staphylococcus epidermidis and Bacillus 
spp.
19 Dec-97 17 9 months Staphylococcus aureus and Bacillus spp.
20 Jan-98 14 10 months Staphylococcus aureus and Streptococcus 
spp.
21 Feb-98 17 11 months Staphylococcus aureus, Streptococcus 
spp. and Bacillus spp.
22 Mar-98 17 12 months Staphylococcus aureus
Table 6 (cont.): Bacteriology results from weekly and monthly bulk milk samples 
taken during the one year monitoring period following ‘blitz therapy’.
4.3.1.2. Somatic cell counting
The weekly BMSCCs were within the EC directive 92/46 standard limits (< 400,000 
cells/ml) except on three weekly occasions, once each in July 1997, February 1998 
and March 1998 (Table 7). However, the monthly BMSCC, based on the three
month geometric mean, for one year after the ‘blitz therapy’ were all less than
400,000 cells/ml. Figure 6 demonstrates the trend in BMSCC over the one year
monitoring period and compares it with the two years prior to the investigations.
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Figure 6: Bulk milk somatic cell counts (BMSCC) for two years prior to the ‘blitz 
therapy’, and the one year monitoring period following it.
 denotes the maximum BMSCC acceptable under the EC Health and Hygiene
directive 92/46.
A decrease in BMSCC was seen after the first farm visit in December 1996. The 
milking routine improvements and the ‘Five Point Plan’ were implemented in 
February 1997 and the ‘blitz therapy’ occurred in March 1997. From Figure 6 it can 
be seen that the BMSCC showed an immediate reduction. This decrease continued 
until November 1997 at which time there was the lowest BMSCC. This level was 
maintained until December 1997 after which a steady increase was seen. However, 
the BMSCC was maintained below 400,000 cells/ml for one year after the ‘blitz 
therapy’.
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4.3.2. Herd screening
4.3.2.1. Bacteriology
All cows which were in milk at the time of the first two herd screenings were 
sampled to monitor for any reoccurrence o f S. agalactiae infection, and cows were 
selected to monitor the prevalence of S. aureus, in addition to the presence of S. 
agalactiae infection, at the next two visits. Herd sampling was undertaken in April
1997 (one month after the ‘blitz therapy’), October 1997 (seven months after the 
‘blitz therapy’), November 1997 (eight months after the ‘blitz therapy’) and January
1998 (ten months after the ‘blitz therapy’).
Streptococcus agalactiae infection was identified in only one quarter of one cow 
during the April 1997 herd sampling. This cow was dry at the time of the ‘blitz 
therapy’ and calved on the 23rd March 1997 when her milk was withheld from the 
bulk tank for an extra week as she had calved within a week of ‘blitz therapy’. After 
isolation o f S. agalactiae in the April 1997 herd screening, this cow was 
subsequently treated using the regime for lactating cows during the ‘blitz therapy’, 
i.e. treated with nafcillin intramammary infusions and parenteral penicillin once daily 
for three days. The cow was separated from the herd and milked using a different 
milking machine. Following treatment, the cow was re-sampled prior to re-joining 
the herd. On repeat sampling the cow was found to be free from S. agalactiae 
infection. The other cows which were dry at the time o f the ‘blitz therapy’ were 
sampled to ensure that they had no remaining S. agalactiae infection. 
Bacteriological culture of milk samples from these cows failed to detect any 
infection.
There was no further evidence o f S. agalactiae infection in any cows from any of the 
herd samples. However, S. aureus was identified from several cows and often on 
repeated occasions. Table 8 demonstrates the cows from which S. aureus was 
identified and when it was identified.
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Cow ID Dec-96/ Jan-97 Apr-97 Oct-97 Nov-97 Jan-98
10 + + +
16 + + +
28 +
29 + +
35 + +
69 +
71 + +
204 +
3P + +
A4 +
A6 + +
A8 + +
A10 +
B5 + +
B8 +
CIO + +
D1 +
D5 + +
D8 +
DIO +
F3 +
F6 + +
F9 +
F10 +
Table 8: Cows from which S. aureus was identified, and the month(s) in which it 
was identified.
Cow identification as detailed in Appendix 6.
An example of the full results as recorded in the database for an individual cow are 
presented in tabular form in Appendix 1.
4.3.2.2. Individual cow somatic cell counting
The first two ICSCC samples which were taken during the herd screening were 
compared to the ICSCC taken in November 1996 prior to intervention using the one 
way ANOVA test followed by a Newman-Keuls multiple range test (Chapter
2.4.4.1.1.) to identify at which times there were significant differences in ICSCC. 
ICSCC were compared between times one (pre-intervention), two and three (post­
intervention). Cow was entered into the model as a random effect to control for 
variation attributable to individual animals. The post-intervention ICSCC at both
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post-intervention screenings were significantly lower than pre-intervention 
(p=0.001).
4.3.3. Costings
4.3.3.1. Cost of monitoring
In total, there were 22 bulk milk samples collected for bacteriological examination, 
costing £220 over the one year herd monitoring period. The bacteriological 
examination o f the individual quarter or individual cow samples taken during the 
four herd screenings cost a total o f £3,870, and the IQSCC cost £246 for the four 
herd screenings. Therefore, the total cost o f the herd monitoring for one year after 
the ‘blitz therapy’ was £4,336. The total costs are itemised in Table 9.
Analysis Type of 
sample
No. of samples Cost of analysis Calculatio
n
Total
Bacteriology Bulk tank 
samples
22 £10 per sample 10x 2 2 £220
Bacteriology Herd 
screenings on 
four occasions
387 £10 per sample 10x387 £3870
Somatic cell 
counting
Herd 
screenings on 
four occasions
492 50 pence per 
sample
0.5 x 492 £246
TOTAL COS" £4336
Table 9: Costs involved in monitoring the herd after the ‘blitz therapy’.
4.3.3.2. Effects of somatic cell counts on production
Due to the fact that the BMSCC remained below 400,000 cells/ml for one year after 
the ‘blitz therapy’ there was no penalties imposed, and it was assumed that there was 
no reduction in milk yield. Therefore, the farmer should have been able to earn £11 
more each day, giving a potential increase in income of £4,015 per year.
4.4. Discussion
It can be seen from the bulk milk samples that the BMSCC was maintained below 
the EC standard of 400,000 cells/ml for at least one year after whole herd ‘blitz
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therapy’ was performed in this herd (Figure 4). Streptococcus agalactiae infections 
were successfully eliminated from this herd, despite the isolation o f this bacteria 
from one cow following the ‘blitz therapy’. However, there did not appear to be any 
beneficial effect on the S. aureus infections.
The bacteriologists reported that CAMP testing was carried out on any Streptococcus 
spp. isolated from this farm. This identification process is not standard procedure, 
but was performed in order to be confident that S. agalactiae had not re-appeared in 
this herd.
The isolation o f S. agalactiae infection from a single cow following treatment 
suggested that the amoxycillin combined with clavulanic acid (Synulox, Pfizer Ltd, 
Sandwich) regime in the dry period may have been an inadequate treatment for S. 
agalactiae infection. The occurrence o f infection in this cow highlights how 
important it is to pay careful attention to the dry cows when undertaking ‘blitz 
therapy’. However, the cow may have become infected in the period after calving 
and prior to the herd screening. The infection in this cow could potentially have 
spread to the rest o f the herd resulting in failure o f the ‘blitz therapy’ approach. The 
improvements made to the milking routine may have played an important part in 
restricting the spread of the S. agalactiae infection from this cow to the others in the 
herd. Following elimination o f the bacteria from this cow, the other dry cows were 
sampled after calving to verify that they were free of infection prior to joining the 
milking herd. All other cows which were treated during their dry period were found 
to be free of S. agalactiae infection after calving.
The cure rate for S. agalactiae infection in this study was 98.2%. High cure rates 
have been achieved by others, using various other intramammary or parenteral 
antibiotics. Moss and others (1998) reported a 98.7% cure rate using a three day 
course of injectable penethamate hydroiodide, no intramammary preparations were 
used. Roberts and others (1963) achieved 90% eradication using intramammary 
penicillin. Weaver and others (1986) recorded a 90% recovery rate using a one or 
two day course of intramammary procaine penicillin G, with and without,
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novobiocin. Bushnell (1980) reported expected cure rates of > 90% using a single 
infusion o f intramammary procaine penicillin G. Procaine penicillin G cured 89.8% 
of cows with S. agalactiae infection in a study by Deneke and others (1993). Erskine 
and Eberhart (1990) reported that S. agalactiae infections were eliminated using 
intramammary infusions o f a procaine penicillin and novobiocin preparation from 
88.6% of treated cows. Zecconi and others (1993) achieved a 88.2% cure rate in 
lactating cows, using penethamate hydroiodide/dihydrostreptomycin preparation, and 
a 90% cure rate in dry cows. Johnston (1975) reported the eradication o f S. 
agalactiae from three herds using erythromycin intramammary infusions, the initial 
cure rate was 77% with some more responding to repeat treatments. Cefoperazone 
treatment of S. agalactiae infected quarters was reported by Bertocchi (1991) to 
reduce infection in four herds to zero in six to fourteen months.
The outlay for the investigations (Chapter 2), treatments (Chapter 3) and monitoring 
in this herd totaled £6,890, while the estimated gain in milk yield for the year was 
worth £4,015. Therefore, it woul take twenty and a half months to pay for the 
intrevention on this farm. The calculations were simplified by being based on the 
lack of penalties following successful reduction in BMSCC, at an average milk price 
of 22 ppl for 1997.
Comparison o f the costs for implementation of ‘blitz therapy’, and for monitoring the 
herd, shows that the monitoring exercise was the more expensive element (£4,336 
versus £2,708). However, due to the poor management of this herd it was decided to 
monitor the herd closely in order to provide a continual incentive to the farmer to 
improve and maintain the hygiene of the milking routine. Unfortunately, the record 
keeping remained poor, and mastitis cases and treatment administered were still not 
recorded adequately, even though it was a legal requirement to record medicine 
useage on farms. However, calving dates and service dates were recorded.
The repeated isolation of S. aureus from bulk milk samples, especially over the last 
four months o f the monitoring exercise, where S. aureus was isolated from 
consecutive samples, and the increase in the BMSCC over this period suggested that
infection with S. aureus was not controlled adequately by the total herd ‘blitz 
therapy’, and/or improvements in the milking routine. Measures to reduce the S. 
aureus infection were planned and implemented and these are discussed in Chapter 5.
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Chapter 5 
Attempted reduction of Staphylococcus aureus 
infection in high cell count cows
5.1. Introduction
Staphylococcus aureus is a contagious mastitis pathogen which most often causes 
chronic subclinical infections with clinical cases occurring only occasionally (Cullor 
and Tyler, 1996). Staphylococcus aureus is difficult to eliminate from a herd due to: 
(1) its ability to survive for extended periods on the skin (McDonald, 1977), (2) its 
ability to survive within neutrophils (Craven and Anderson, 1979; Madgwick and 
others, 1989; Sandholm and others, 1990; Bramley, 1992) and, (3) poor 
bacteriological cure following antibiotic treatment (Ziv, 1980; Bramley and Dodd, 
1984; Fox and Gay, 1993). There are different strains o f S. aureus which have 
varying virulence and some produce p-lactamase which makes them resistant to 
penicillins (Sandholm and others, 1990; McKellar, 1991; Fox and Gay, 1993; 
Vestweber and Leipold, 1993). The 'Five Point Plan' is an important control measure 
for contagious mastitis and can bring about a reduction in the spread of S. aureus 
(Smith and Hogan, 1996), but for eradication purposes, segregation and culling of 
individual cows may be necessary (Wilson, 1980; David, 1993).
Initial milk samples collected from a pre-selected sample o f the herd in December 
1996 showed that, 42.9% (9/21) o f cows had S. aureus infection in one or more 
quarters (Chapter 2.5.2.3 and Chapter 2.5.3.). Staphylococcus aureus was isolated 
from 10 o f the 22 bulk milk samples taken during the one year monitoring period 
(Chapter 4.3.1.1.). Results of bacteriological examinations of samples from the last 
four herd screenings showed that 27.9% (24/86) of cows had S. aureus infections, 
and, of these S. aureus infection had been detected in eight cows on more than one
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occasion (Table 8).
Whole herd ‘blitz therapy’ was aimed primarily at eliminating S. agalactiae from this 
herd (Chapter 3). The response to the treatment was monitored closely over the 
following year by sampling from the bulk tank and herd screening (Chapter 4). On 
identifying the high prevalence o f S. aureus infection in the herd and the gradual rise 
in BMSCC towards the end of the one year monitoring period, it was decided to 
implement further control measures in an attempt to reduce and control infections 
with S. aureus. For this to occur the organism had to be eliminated from individual 
chronically affected cows.
5.2. M aterials and methods
5.2.1. Cow selection
Six cows were chosen, based on repeated bacteriological samples, for treatment. 
Cows in which S. aureus infection was detected, especially in more than one milk 
sample, and which were lactating at the time of the proposed trial treatment were 
selected. Three cows in their first lactation and three cows in later lactations were 
selected for therapy. The cows used in this study were three to seven years old and 
their ICSCC varied from 11,000 to 7,010,000 cells/ml. Their identity and 
bacteriological history are shown in Table 10. Appendix 7 summarises the 
bacteriology results for all the cows in the herd, highlighting the cows from which S. 
aureus was isolated. Table 11 summarises the ages, the ICSCCs and the 
bacteriological information for the six cows which were selected for treatment to 
attempt to reduce S. aureus infection.
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Cow
ID
Isolation of Staphylococcus aureus
Dec-96/Jan-97 Apr-97 Oct-97 Nov-97 Jan-98
If lh rf rh If lh rf rh comp If lh rf rh If lh rf rh
10 - + - + n n n n + n n n n - + - -
A6 n n n - n n n n + n n n n + n n +
D5 n - n n n - n - n - + - + - + - -
F3 n n n n n n n n n + + - + - - n -
F6 n n n n n n n n n - + - + - + - -
F10 n n n n n n n n n n n n n - + - +
Table 10: Bacteriology results o f cows which were selected for treatment, indicating 
when and in which quarters Staphylococcus aureus was isolated.
+ indicates that Staphylococcus aureus was isolated. - indicates that Staphylococcus 
aureus was not isolated, n indicates that a sample was not collected for examination, 
comp. - composite milk sample. If - left front quarter, lh - left hind quarter, r f  - 
right front quarter, rh - right hind quarter.
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5.2.1.1. Antibiotic treatment
The main criterion for selection o f antibiotics was efficacy against S. aureus. Secondary, but 
important, considerations were milk withdrawal periods and cost of the antibiotic. Ceftiofur 
(Excenel Sterile Powder, Pharmacia and Upjohn Limited Limited, Corby), a p-lactamase 
resistant, broad spectrum, bactericidal cephalosporin antibiotic preparation for parenteral 
administration was selected (Prescott and Baggot, 1993; Anon, 1998). Ceftiofur (Excenel 
Sterile Powder, Pharmacia and Upjohn Limited Limited, Corby) was selected for its excellent 
efficacy against gram-positive bacteria and because o f the nil milk withdrawal period for this 
drug. Treatment was given for a prolonged period, ten days instead of the recommended 
standard three to five days, in order to increase the chance of clearance of the S. aureus 
infection from the mammary gland of the cows.
5.2.1.2. Treatment protocol
The six cows selected for treatment against S. aureus infection were injected once daily for 
ten days. Ceftiofur (Excenel Sterile Powder, Pharmacia and Upjohn Limited Limited, Corby) 
was administered by intramuscular injection once daily for 10 days at a dose rate o f 1 mg/kg 
by veterinary personnel every morning following milking. The cows averaged 500 kg, 
therefore were given a daily dosage of 50mg.
5.2.2. Milk samples
5.2.2.I. Bacteriology
In order to monitor the response to ceftiofur (Excenel Sterile Powder, Pharmacia and Upjohn 
Limited Limited, Corby) therapy, milk samples were collected starting four days after the end 
of the ten day treatment period and bacteriological culture was performed on all samples. 
Composite milk samples were collected from individual cows using a sterile sampling 
technique (Chapter 2.4.2.3.), prior to milking in the morning. Composite milk samples and 
bulk milk samples were collected at the start o f the treatment and then collected on a weekly 
basis for six weeks after the ceftiofur (Excenel Sterile Powder, Pharmacia and Upjohn 
Limited, Corby) treatment.
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5.2.3. Costings
Costs were obtained for the ceftiofur (Excenel Sterile Powder, Pharmacia and Upjohn 
Limited, Corby) used and for the sterile water (Water for Injection, Animalcare, York), which 
was used to suspend the antibiotic. Estimated costs for labour were not included. Also 
included in the costing was the cost o f bacteriological examinations o f the milk samples 
collected before and after the treatment to monitor the response to treatment. The standard 
charge o f £10 per sample was made. A 4g vial of ceftiofur (Excenel Sterile Powder, 
Pharmacia and Upjohn Limited, Corby) cost £24.30 and 100 ml o f sterile water (Water for 
Injection, Animalcare, York) cost £1.80. To reconstitute the powder 80 ml o f sterile water 
were required and this worked out that 1 ml essentially provided 50 mg of ceftiofur (Excenel 
Sterile Powder, Pharmacia and Upjohn Limited, Corby). Therefore each cow required 10 ml 
o f the reconstituted drug. The cost of a bottle of the reconstituted drug was £25.74 and every 
cow needed 1.25 bottles, working out at a cost o f £32.20 per cow for the ten day treatment.
5.3. Results
5.3.1. Treatment
The six selected cows were all given daily intramuscular injections of 1 mg/kg ceftiofur 
(Excenel Sterile Powder, Pharmacia and Upjohn Limited, Corby) for ten consecutive days. 
Treatment was initiated on the 10th March 1998.
5.3.2. Bacteriology
The bacteriology results, for milk samples from the six cows and the bulk tank, are given in 
Table 12. Staphylococcus aureus infection was detected in five o f the six cows after the 
ceftiofur (Excenel Sterile Powder, Pharmacia and Upjohn Limited, Corby) treatment was 
administered. However, the number of S. aureus colonies detected on culture o f the milk 
samples was reduced in comparison to the pre-treatment samples, only one or two colonies 
were recorded in the follow up samples instead o f the profuse growths which were detected 
prior to treatment. One first lactation cow (F3) was found to have no S. aureus in any of the
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six weekly samples. The other two first lactation cows (F6 and F10) were positive on five o f 
the six occasions. Staphylococcus aureus was isolated from all six bulk milk samples.
Week
no.
Date Bulk
milk
Cow identification
10 A6 D5 F3 F6 F10
1 10/3/97 + + + + - + +
2 17/3/97 + + + + - - +
3 25/3/97 + + + + - + -
4 1/4/97 + + DRY + - + +
5 8/4/97 + DRY DRY DRY - + +
6 16/4/97 + DRY DRY DRY - + +
Table 12: Isolation of Staphylococcus aureus in six cows following treatment with ceftiofur 
(Excenel Sterile Powder, Pharmacia and Upjohn Limited, Corby).
+ indicate that Staphylococcus aureus was isolated. - indicates that Staphylococcus aureus 
was not isolated
5.3.3. Costings
In total there were 35 milk samples submitted for bacteriological examination. Therefore, the 
monitoring cost £350.
Ceftiofur administered at a dose rate of 1 mg/kg for the six cows for the treatment period of 
ten days resulted in a total o f 500 mg/cow for each of the six cows for the treatment period, 
i.e. 7.5 vials of ceftiofur and 640 ml sterile water (Water for Injection, Animalcare, York). 
The total cost o f the treatment was £194 and with a 50% mark up the cost o f the drugs was 
£291. Therefore, the total cost involved in attempting to reduce the S. aureus infection in six 
clinical carriers in this herd was £641.
5.4. Problems encountered during the treatment regime
Three of the cows selected for treatment could not be sampled for the full six weeks. One of 
these cows was sampled for three weeks only and the other two were sampled for four weeks. 
O f the three cows which were not sampled for the entire six weeks, two (10 and D5) were not
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sampled for the agreed six weeks because they were dried off due to low milk yield. These 
cows were not due to calve for a further three and five months respectively, but had been 
lactating for 10.5 and 4.5 months respectively. These low yielding cows were dried off and 
given DCT because their milk would have increased the BMSCC had it entered the bulk tank. 
The third cow (A6) was due to calve in one month and, therefore, was dried off and given 
DCT. The three cows which were sampled for the full six weeks were the first lactation cows. 
One cow (F3) had no S. aureus isolated during the six week sampling period. However, the 
last milk sample collected prior to the ceftiofur (Excenel Sterile Powder, Pharmacia and 
Upjohn Limited, Corby) treatment was also negative for S. aureus infection, in spite o f S. 
aureus being present in three quarters on one occasion five months before this treatment was 
attempted.
5.5. Discussion
At the time o f treatment, it was hypothesised that the three first lactation cows were likely to 
respond better than the three older cows, because in younger cows, infections were likely to 
be new and the cows’ immune system was likely to respond more effectively (McKellar, 
personal communication). Infections in older cows tend to have a longer duration and cause 
more extensive tissue damage than in younger cows (Reneau, 1986).
The results of bacteriological examinations showed that S. aureus was not eliminated from 
any of the six cows treated with ceftiofur. In five cows infection was continued and in one 
cow (F3) infection was likely to have been eliminated prior to treatment with ceftiofur 
(Excenel Sterile Powder, Pharmacia and Upjohn Limited, Corby). However, the level of 
infection was considered to be reduced as there were only one or two colonies cultured on the 
agar plates following the antibiotic treatment. The first lactation cow (F3) from which S. 
aureus infection was not detected at any point during this study may have cleared the 
infection spontaneously prior to the ceftiofur (Excenel Sterile Powder, Pharmacia and Upjohn 
Limited, Corby) treatment or alternatively the cow may have only been shedding S. aureus 
intermittently. This reduction in the level of infection should have, in the short term,
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increased the cows’ milk yields and reduced the ICSCC, unfortunately due to farm 
circumstances neither the cows’ milk yield or ICSCC were monitored.
The parenteral penicillin and the intramammary nafcillin which were used for the ‘blitz 
therapy’ (Chapter 3.2.2) appeared to have a minimal affect on the S. aureus infections 
therefore a different approach was required. It was decided to attempt reduction of the S. 
aureus infections in this herd using a parenteral treatment for a prolonged period. Treatment 
was administered for a prolonged period (ten days) in order to exceed the lifespan of 
neutrophils thereby allowing the antibiotic to be effective against intracellular bacteria 
(Belschner and Sears, 1998; McKellar, personal communication). Neutrophils survive in the 
circulation for 7-14 hours and in the tissue for 2-3 days, giving a total lifespan of 3-4 days 
(Jain, 1993). Belschner and Sears (1998) found that an extended treatment period of ten days 
did improve the clinical cure rate of chronic S. aureus infection. Ceftiofur (Excenel Sterile 
Powder, Pharmacia and Upjohn Limited Limited, Corby) was chosen due to its known 
effacacy against gram-positive bacteria and nil milk withdrawal period. It was hoped that the 
systemic route would allow better distribution within the udder tissue. Given that the selected 
cows had high SCCs and had been identified as S. aureus infected there would have been a 
degree of inflammation in the udder and it was thought that the cephalosporin would be able 
to cross into the milk. However, after the six week period when it was realised that the 
treatment had been unsuccessful, milk samples, which had been taken during the treatment 
period and stored, were checked for the presence o f any inhibitory products. To investigate 
for the presence o f any inhibitory products milk samples taken after the initiation o f treatment 
were cultured along with S. aureus and another susceptible Staphylococcus aureus (1964 
Compton strain), if  there were inhibitory products present the expectation was that these 
bacteria would be unable to grow. From this test procedure, there was no evidence o f any 
inhibitory products in the milk samples, thereby explaining, in part, the failure o f the 
parenteral ceftiofur (Excenel Sterile Powder, Pharmacia and Upjohn Limited Limited, Corby) 
to reduce the S. aureus infection.
98
The cure rate o f S. aureus intramammary infections can be influenced by localisation of 
infection within the quarter, the age of the cow, persistence o f shedding of S. aureus before 
drying off, the SCC of infected quarters, and the number o f quarters infected with S. aureus 
per cow (Sol and others, 1994). The probability o f eliminating S. aureus infection decreases 
with increasing SCC and age (Sol and others, 1994). The possible cure rate in this study was 
one out o f six cows (16%), and this was probably due to self cure prior to ceftiofur treatment 
as the sample taken immediately before treatment was found to be free o f S. aureus. 
However, this figure cannot be extrapolated to other herds because o f the small number of 
animals involved. It can be concluded, in agreement with previous work that attempts to 
eliminate S. aureus using antibiotic treatment during lactation is unlikely to be successful. In 
this study and in work by Soback and others (1989) it was found that parenteral ceftiofur had 
no activity in milk and would not be an antibiotic o f choice for the treatment o f high SCC 
cows by the systemic route.
5.6. F u rther work
Further control measures could include changing the antibiotic preparation used for routine 
DCT to a preparation with better activity against S. aureus and longer persistence . It was 
shown by Marco and others (1996) that cloxacillin (Orbenin Extra DC, Pfizer Ltd, Sandwich) 
used at drying off resulted in greater cure rates than cephalonium (Cepravin dry cow, 
Schering-Plough Animal Health, Uxbridge) and cloxacillin and ampicillin (Kloxerate Plus, 
Fort Dodge Animal Health, Southampton), and had a good action against S. aureus infections, 
with cure rates of 72.7% as compared to 58.1% and 55.4% with the other preparations 
respectively.
Two cows (10 and D5) were given a three day course o f parenteral tylosin (Tylan 200, Elanco 
Products Limited, Basingstoke) at drying off, accompanied by DCT using cloxacillin 
(Orbenin Extra DC, Pfizer Ltd, Sandwich). Tylosin (Tylan 200, Elanco Products Limited, 
Basingstoke) was chosen because of its good tissue distribution, high intracellular 
concentrations and activity against gram-positive organisms. However, this product is only
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licensed for intramuscular use and has a long milk withdrawal period. Therefore the treatment 
was given parenterally at drying off. The cows will be sampled, weekly for six weeks, after 
calving to monitor for the presence of S. aureus infection. At the time of writing, these cows 
have yet to calve.
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Chapter 6 
General discussion
Mastitis is a very important disease with huge economic implications to the dairy industry 
(Janzen, 1970; Wilson and Kingwill, 1975; Booth, 1988; Sischo and others, 1990; Bramley, 
1992; Esslemont and Peeler, 1993; Smith and Hogan, 1993; Muldoon, 1995; Rebhun, 1995). 
The adoption o f the European Community Health and Hygiene Directive 92/46 a the farm 
gate in January 1998 forced farmers to pay greater attention to the control of mastitis in order 
to produce milk o f a sufficient standard to meet market requirements. The crisis affecting the 
farming industry of the UK over recent months, in the aftermath of BSE has led to depressed 
incomes for dairy farmers. Decreasing milk and stock prices have meant that farmers need to 
be able to produce milk ever more efficiently, which in turn, necessitates excellent disease 
control in order to mitigate the negative effects o f ill health on productivity.
Mastitis control depends largely on good herd management and milking hygiene, and strict 
adherence to the ‘Five Point Plan’ (Booth, 1975b; Jackson, 1980; Smith and Hogan, 1996). 
Herd recording is an essential part o f determining and monitoring the prevalence o f disease. 
The recording of clinical cases o f mastitis may increase the farmer’s awareness o f the disease 
and thus lead to the identification o f recurrent or persistent cases (Blowey, 1986). Prompt 
treatment of clinical cases and the removal o f recurrently or persistently infected cows will 
reduce the risk o f spread o f infection to other cows. The possibility of breeding for increased 
resistance to mastitis infection is the subject of ongoing research (Hamori, 1980; Shook, 
1993).
The sixty cow dairy herd which provided the basis for this study had a persistently increased 
BMSCC for quota years 1995/1996 and 1996/1997. The milk company purchasing the milk 
were threatening to terminate the contract with the farmer if  there was no attempt to improve
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this situation. It was subsequent to this warning that the farmer sought veterinary advice and 
investigation o f milk production practices in this herd were initiated in November 1996. The 
investigation began by the examination of historical data from the herd, followed by a farm 
visit where the milking routine and the milking hygiene were observed and assessed. Milk 
samples were collected from cows selected on the basis o f high ICSCC from the historical 
data and a positive CMT result. The milk samples were submitted for further investigations. 
Bacteriological examinations were carried out on the milk samples collected and it was found 
that 67% of the cows sampled were infected with S. agalactiae and 33% were infected with S. 
aureus. The buildings and cubicles were, in general, in a poor state o f repair.
Immediate implementation o f control measures were essential to prevent the farmer going out 
o f business. Careful consideration o f the historical information, and the results o f a series of 
on-farm investigations, led to the implementation of control measures comprising the 
coordinated adoption o f the ‘Five Point Plan’, in combination with whole herd ‘blitz therapy’ 
to eliminate infection with S. agalactiae. Further control measures involving improving the 
milking routine and farm records were also implemented: udders were washed using running 
water from a hose, separate paper towels were used to dry the udder o f each cow, clusters 
were regularly dipped in disinfectant during the milking process, iodine based teat disinfectant 
was used as a post-milking teat dip after each milking, routine DCT was carried out and 
improvements were made to the cleaning of the milking line and data recording.
The whole herd ‘blitz therapy’ consisted o f a combined regime of intramammary and 
parenteral antibiotics. The choice o f antibiotics was made with the primary aim of 
eliminating S. agalactiae and the secondary aim to reduce S. aureus. This regime was chosen 
to ensure adequate tissue distribution and penetration by the antibiotics. It was considered to 
be the therapy most likely to achieve the combined study objectives, and was the only course 
of action likely to avoid the milk company refusing to purchase milk from this farm. The 
selection of antibiotics was influenced by the preparations available, by the desired route, the 
requirement for once daily administration because of reliance on veterinary administration, 
and the length o f the milk withdrawal period. Concern about antibiotic residues in milk
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resulted in intramammary DCT not being implemented. There were dry cow preparations 
available with short withdrawal periods o f seven days which could have been used, but the 
farmer could not be relied upon to identify the cows correctly and antibiotic contamination o f 
the bulk tank may have been the result. However, for this herd, parenteral treatment with 
amoxycillin combined with clavulanic acid (Synulox RTU, Pfizer Ltd, Sandwich) was used as 
the antibiotic in the ‘blitz therapy’ for the non-lactating cows. This antibiotic was selected as 
it is a broad spectrum antibiotic with resistance to (3-lactamase producing S. aureus.
The identification of S. agalactiae in a single cow one month after the ‘blitz therapy’ caused 
concern about the efficacy of the chosen therapy. This cow was dry during the ‘blitz therapy’ 
and, therefore, received a three day course o f amoxycillin combined with clavulanic acid 
(Synulox RTU, Pfizer Ltd, Sandwich). The cow calved three days after the last day of the 
‘blitz therapy’ and, as a result, her milk was discarded for an additional week i.e. it was ten 
days after the ‘blitz therapy’ before her milk was allowed to be sold for human consumption. 
New infections are considered to be the most common and most logical explanation for 
apparent treatment failures (Sandholm and others, 1990). There are two possible theories to 
explain the re-occurrence of S. agalactiae: (1) the possibility that infection may have survived 
in the udder following the ‘blitz therapy’ or, (2) new infection may have occurred in the 
period between calving and the first herd screen, one month after the ‘blitz therapy’. The other 
cows which were treated during their dry period were subsequently sampled after calving to 
ensure that they were not harbouring any S. agalactiae infection. Bacteriological examination 
o f milk samples collected from these cows failed to detect S. agalactiae. Milk samples were 
collected after the second treatment to verify that the infection had been cleared from the 
individual cow from which S. agalactiae was isolated. Streptococcus agalactiae was not 
detected from this cow, or any other cows, or from the bulk tank, for the remainder o f the one 
year monitoring period. The lack o f transmission o f this contagious pathogen prior to 
detection in the cow may suggest that the infection was a failure in treatment rather than a 
new infection.
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It was concluded that the ‘blitz therapy’ was successful in eliminating S. agalactiae from this 
herd. The BMSCC was maintained below the EC standard for one year. The 98% cure rate 
achieved in this study was considered to be very good and was consistent with cure rates 
achieved for herd treatment of S. agalactiae infection in other studies, which ranged from 
88.2% to 98.7% (Bushnell, 1980; Weaver and others, 1986; Erskine and Eberhart, 1990; 
Deneke and others, 1993; Zecconi and others, 1993; Moss and others, 1998). However, the 
BMSCC showed a slight increase in the latter part o f the monitoring period and S. aureus was 
consistently isolated from bulk tank samples from February 1998. This apparent increase in 
S. aureus infection may have been due to the elimination of S. agalactiae infections, allowing 
S. aureus to become more of a problem, perhaps due to the phenomenon of the lack of 
inhibition by other major pathogens (Rainard and others, 1988; Biggs, 1996).
It was decided to attempt to reduce the prevalence o f S. aureus by treating a number of the 
cows with antibiotics. Six cows were selected for initial treatment with a prolonged course of 
parenteral ceftiofur (Excenel sterile powder, Pharmacia Upjohn, Corby). The nil milk 
withdrawal period for this drug due to its high level of safety in humans, reflected by its high 
maximum residue limits, meant that milk need not be discarded from treated cows, thereby 
simplifying the management o f the treated cows. However, the concentration o f ceftiofur 
(Excenel sterile powder, Pharmacia Upjohn, Corby) in milk was assessed to ensure that 
sufficient concentrations o f the drug did penetrate the udder. It was found that there was no 
evidence of any inhibitory products in the milk and therefore it was not surprising that 
ceftiofur (Excenel sterile powder, Pharmacia Upjohn, Corby) was not able to eliminate S. 
aureus infection in these cows. Soback and others (1989) when measuring the concentration 
o f cetiofiir in milk after intravenous or intrmuscular administration failed to find any ceftiofur 
in the milk. Wheeler (1998, personal communication) found that the minimum inhibitory 
concentration of ceftiofur against European isolates of S. aureus was 20 times more than the 
maximum concentration o f ceftiofur which could diffuse into the udder after recommended 
dosing. However, in this study the numbers o f S. aureus colonies were reduced which could 
suggest that some ceftiofur did penetrate the udder, but the cows could also have self-cured. 
The number o f cows which were treated were too few to make any significant statements
104
about the value o f this treatment, although it does suggest that it was not very successful for 
eliminating S. aureus. Watson (1998) suggested that using combined therapy o f parenteral 
tylosin (Tylan 200, Elanco Products Limited, Basingstoke) and intramammary infusions with 
cloxacillin (Orbenin Extra DC, Pfizer Ltd, Sandwich) at drying off may be effective in 
reducing the rate o f new infections and increasing the cure rate of existing infections caused 
by S. aureus. The results from tylosin (Tylan 200, Elanco Products Limited, Basingstoke) 
treatment of two cattle in this herd at drying off are awaited and no judgment can be made to 
date. Further work to find a successful antibiotic for the reduction of S. aureus infections is 
necessary with larger numbers of cows than used in this preliminary study. Biggs (1998) 
showed a favourable SCC response in seven cows with persisitent S. aurues infections using 
10 mg/kg tilmicosin (Micotil, Elanco Products Limited, Basingstoke) at drying off.
The use of intramammary infusions carries with it a risk that bacteria may be accidentally 
introduced into the teat via the teat canal during the infusion process (Murphy and Stuart, 
1954). Boyer (1997) and Edmondson (1997) both reported outbreaks o f clinical mastitis 
following ‘blitz therapy’. In both cases erythromycin intramammary preparations were used, 
the treatments were administered by the farmers, and the teats were prepared for infusion 
using a post-milking teat disinfection. Erythromycin is a narrow spectrum antibiotic, effective 
only against gram-positive bacteria and Mycoplasma spp.. The erythromycin treatments were 
repeated, for two or three consecutive milkings, which increases the risk of introducing 
bacteria into the teat canal. Biggs (1997) reported the use of surgical spirit to prepare teats 
prior to infusion o f penicillin and streptomycin (Streptopen Milking Cow, Mallinckrodt 
Veterinary Ltd, Middlesex) and found no ensuing cases o f clinical mastitis. Surgical spirit 
was used for teat preparation prior to intramammary infusion in the current study, and no 
cases of clinical mastitis following treatment occurred. There are three possible reasons for 
this: either (1) the rapid bactericidal effect of the surgical spirit (Biggs, 1997), or (2) the use of 
broad spectrum antibiotics, or (3) veterinary administration o f the treatments. The use o f only 
one infusion would reduce the risk o f introducing infection (Biggs, 1997), however, in this 
study the treatment o f S. aureus was also attempted and, therefore, a three day course of 
treatment was necessary rather than one infusion which may have been sufficient to combat
105
S. agalactiae.
Bacteriological identification o f S. agalactiae in this study presented some difficulties, 
especially after the ‘blitz therapy’. The bacteriologists needed to re-check all the 
Streptococcus spp. isolated and the CAMP test was required for accurate identification of the 
Streptococcus spp. The thorough identification process ensured that S. agalactiae infection 
would have been detected had it been present. If the examination process had not been as 
thorough, there is the possibility that the bacteria may have been missed and the infection 
could have spread through the herd.
Somatic cells tend to concentrate in the butterfat, as do bacteria (Edmondson, 1998). The 
method o f sampling milk can therefore, produce inaccurate results i.e. artificially high 
BMSCC and high concentrations of bacteria if  the bulk milk is not agitated prior to sampling. 
Edmondson (1998) found that the BMSCCs could vary by two fold depending on the 
sampling technique, depending on whether the sample was taken prior to, or after a sufficient 
period o f agitation o f the milk in the bulk tank. It was recommended that the milk in the bulk 
tank is agitated for at least two minutes prior to collection of a sample for BMSCC 
(Edmondson, 1998) to ensure the milk is adequately mixed. In the current study, bulk milk 
samples which were taken for bacteriological culturing, and possibly those taken for somatic 
cell counting, may not have been taken after a standard period o f agitation and, therefore, the 
isolation of bacteria and the BMSCC may have been affected by this.
The IQSCCs were reduced following ‘blitz therapy’ for almost all the cows. The two cows 
which showed an increase in IQSCCs to > 400,000 cells/ml may have been approaching 
drying off, but unfortunately calving dates were not available and so it is impossible to state 
with any confidence that the increase in IQSCC was an indication of infection. An increase in 
milk yield would be expected following the treatment of the herd, especially as the IQSCC 
were seen to decrease, but individual cow milk recording was not performed on this farm. 
However, the farmer did report that there appeared to be more milk in the bulk tank following 
the ‘blitz therapy’ than before the treatment began. Furthermore, the annual milk records for
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the farm showed that the quantity of milk sold increased for the quota year following the ‘blitz 
therapy’, with the milk sales being very close to the targeted quota for the year (Appendix 8). 
However, this improvement may not have been solely due to the treatment, as the calving 
pattern was unknown so that there may have been more cows in early lactation during this 
period. Other factors such as the quality o f feed and the amount of milk taken for feeding to 
calves may also have contributed to the increased milk sales.
The degree o f compliance of the farmer and her ability to follow instructions on improving 
and making alterations to the milking routine, and implementing the control measures, were 
major considerations in this study. The ‘blitz therapy’ was carried out after recommending 
strict adherence to the ‘Five Point Plan’ with follow up visits to ensure that the management 
changes had been made. It was considered that adoption o f the recommended management 
changes was essential in order to safeguard the success of the treatment programme, as poor 
milking and management practices are known to increase the risk of mastitis (Sandholm and 
others, 1990). Logue and others (1994) reported that deficiencies in the milking routine 
resulted in failure to contain spread o f infection from cows which were not cured, therefore 
allowing the continuation o f S. agalactiae infection, and resulting in the establishment of S. 
aureus infections which were less responsive to antibiotics. These recommendations were 
used to make improvements to the hygienic practices on the farm and to assess the compliance 
o f the farmer to veterinary advice before investing a considerable amount of money and effort 
on extensive treatment o f the herd. In terms of implementation and follow-up, the more 
straight-forward total herd ‘blitz therapy’ regime was chosen instead o f the partial herd ‘blitz’ 
because it was believed that the farmer was unlikely to be committed to the monitoring 
necessary for the partial herd ‘blitz’ regime. Treatments during all studies on this farm were 
administered by veterinary personnel to ensure that the antibiotics were administered correctly 
to the right cows.
Economics should always be considered in the management and treatment o f disease in farm 
animals. The whole herd ‘blitz therapy’ for this herd cost £6,840 which included the costs of 
investigation, treatment and monitoring. The milk yield for the cows in the herd was assumed
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to have increased by 10% after the ‘blitz therapy’, which would mean that the investment in 
investigations, treatments and monitoring would have been paid off after 20.5 months due to 
the increased milk sales alone. Cows were repeatedely screened post-treatment this procedure 
is not essential and could be omited from the ‘blitz therapy’ regime when done commercially. 
The cost of the therapy used was approximately one third o f the total cost and therefore, if  a 
less rigorous monitoring protocol was followed, the costs would have been lower still. In 
order to monitor the response to ‘blitz therapy’, in most instances it would be sufficient to 
monitor the BMSCC, along with periodic bacteriological culture of bulk milk samples 
(McDonald, 1989; Biggs, 1996). If this monitoring procedure had been followed the cost 
could have been as low as £2,193 (cost o f the ‘blitz therapy’ £1,973 and bulk milk 
bacteriological examinations £220). The cost o f this monitoring programme would be paid 
off within four months. These calculations do not include the cost of professional time. 
Professional time priced at £60/hour. Therefore, for the investigations, treatment and 
monitoring involved in this study herd the cost o f professional fees could have amounted to 
£1,800.
At the time of completion of this study in August 1998, the UK price for milk was decreasing 
(20 ppl). In addition to the decrease in the milk price, the continued depression in the market 
for cattle brought about by the BSE crisis has had a considerable impact on the profitability o f 
cattle farming. It is considered likely that consumer pressure will continually demand better 
quality milk and that this will lead to continued pressure on farmers to reduce SCC and TBC. 
Taken together, these factors require the farmer to be able to produce milk of high quality in 
an efficient and cost effective manner. The control of subclinical mastitis is, therefore, an 
essential area, which as demonstrated in this study, can dramatically increase profitability of 
farms.
The ‘blitz therapy’ and control measures would be cost-effective in the study farm after 20.5 
months, and the rapid reduction in BMSCC which was maintained for at least one year 
demonstrates that veterinary involvement was definitely beneficial. The mastitis problem in 
this dairy farm involved investigation, treatment and careful monitoring. The future for this
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farm, however, is still uncertain due to the current economic constraints on the farming 
industry in general, and due to the continuing high prevalence o f S. aureus infection in the 
herd.
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Appendix 1
Sample form giving details recorded for each cow
os
110
0 2 /06/97
I f f f l lS W .
Staphylococcus aureus, Bacillus spp
Staphylococcus epidermidis, Bacillus spp., Streptococcu
I:::::::::::::!:::::::::!::;::
3334
Staphylococcus aureus 
4CSCC
•oiogy
I l l
Appendix 2
Monthly bulk milk somatic cell counts (BMSCC) for quota 
years 1995-1996 and 1996-1997
112
Quota Years
1995 -  1996
Year Month BMSCC xlO3 cells/ml
1995 April 478
May 358
June 385
July 352
Aug 311
Sept 310
Oct 290
Nov 446
Dec 495
1996 Jan 387
Feb 545
March 612
1996 -  1997
Year Month BMSCC xlO3 cells/ml
1996 April 537
May 628
June 572
July 448
Aug 619
Sept 562
Oct 704
Nov 613
Dec 735*
1997 Jan 677
Feb 470**
March 502#
* Start of investigations.
** Implementation of improved milking routine.
# ‘Blitz therapy’ performed.
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Appendix 3
Individual cow somatic cell counts (ICSCC) for those cow 
lactating during November 1996
114
Cow ID ICSCC X  l(l7ml
C5 14
A7 16
D8 17
204 19
D9 31
C6 32
A2 45
140 V 57
D16 65
B1 79
58 93
D15 101
D2 149
C15 212
A1 260
C12 282
D5 409
16 480
10 613
Cl 703
A6 783
DIO 871
A8 1030
A4 1543
35 1812
71 1983
B5 2190
3 2632
D3 3115
C16 3155
5 3292
3P 3866
B8 3941
6 4065
B4 4168
261 4395
28 9714
29 10738
69 18077
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Appendix 4
Sample sheets allowing calculation of calving dates
-Service-- - - - - - - „— Due to  calve
Jan  1 Oct 8
9 — -=> 9
3 — 10
4 — ~ 9  H
3 — - 9  12
6 — -2 >  13
7 — - 9  14
8 J - 9  15
9 — - >  16
10 _ 9  17
11 IB
12 ^  19
13 — 20
14 — - 9  21
15 L ^ >  22
16 ~ 9  23
17 _ 24
18 — 25
19 26
20 - >  27
2! - - >  28
22 — - >  29
23 •— 30
21 — - >  31
23 — Nov 1
26 s?  2
27 — - 9
28 ^  429 - p  5
30 — 9  6
) 1 _ >  7
• )  i h-3>
Feb 1 — -~9> 8
9 __ 9
0I — ~3> 10
4 S >  11
5 — 12
j 6 — - >  13
7 — ^  H
8 — 9  15
9 — - 9  16
10 — ~ 9  17
11 ~ 9  181 1 2  — - - 5  19
13 “ -~j> 20
| 11 ■9 21
j 15 - 9  22
i 16 - 28
- 9  24
j 18 — - 9  25
19 H - 9  86
1 20 - J - 9  2 7  j
Service
Feb 21
Due to calve
Nov 28
Dec
Mar
Ja n
-~9
* — i.
—-9
117Due to calve
Jan  18
Service Due to calve
JuneApr 13 Mar 15
Feb
__
Mar
i
f—
May
Due to  c a lv e 1Due to  calve
J u n e  29
28
30 7>
T
] 19
Service
Nov 12
Due to calve
Aug 19 
20 
21
22
23
24
25
26
27
28
29
30
31 
Sep 1
2
Service
Dec 7
Due to calve
20
22
23
38
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Appendix 5
Sample sheets for recording reproductive data, mastitis 
cases and treatments administered
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Appendix 6
Treatments administered during ‘blitz therapy’
123
Cow ID Treatment
administered
Category
3 - SOLD
5 Depocillin and 
Nafpenzal
Early lactation (2 months calved)
6 - SOLD
10 Depocillin and 
Nafpenzal
Late lactation (calved 2 months after 
treatment)
16 Synulox Dry
28 Depocillin and 
Nafpenzal
Early lactation (calved 8 months after 
treatment)
29 Depocillin and 
Nafpenzal
Unknown
35 Depocillin and 
Nafpenzal
Unknown
57 Depocillin and 
Nafpenzal
Early lactation (10 days calved)
58 Depocillin and 
Nafpenzal
Unknown
69 Synulox Dry (calved 1 month after treatment)
71 Depocillin and 
Nafpenzal
Unknown
133 Depocillin and 
Nafpenzal
Early lactation (calved 2.5 months)
MOV Depocillin and 
Nafpenzal
Unknown
204 Depocillin and 
Nafpenzal
Early lactation (calved 8 months after 
treatment)
261 - SOLD
3P Synulox Dry (calved 2 weeks after treatment)
A1 Depocillin and 
Nafpenzal
Unknown
A2 Depocillin and 
Nafpenzal
Mid lactation (calved 4 months after 
treatment)
A4 Depocillin and 
Nafpenzal
Unknown
A6 Depocillin and 
Nafpenzal
Late lactation (calved 2 months after 
treatment)
A7 Depocillin and 
Nafpenzal
Unknown
A 8 Synulox Dry (calved 2 weeks after treatment)
A9 Depocillin and 
Nafpenzal
Early lactation (calved 9 months after 
treatment)
A10 Depocillin and 
Nafpenzal
Early lactation (calved 2 months)
124
B1 Depocillin and 
Nafpenzal
Unknown
B3 Depocillin and 
Nafpenzal
Early lactation (calved 2 months)
B4 Depocillin and 
Nafpenzal
Unknown
B5 Synulox Dry (calved 4 days after treatment)
Cl Synulox Dry
C2 Depocillin and 
Nafpenzal
Unknown
C5 Depocillin and 
Nafpenzal
Unknown
C6 Depocillin and 
Nafpenzal
Mid lactation (calved 6 months after 
treatment)
C l Synulox Dry (calved 3 weeks after treatment)
C8 Depocillin and 
Nafpenzal
Unknown
CIO Depocillin and 
Nafpenzal
Early lactation (calved 7 months after 
treatment)
C ll Synulox Dry (calved 6 weeks after treatment)
C12 Synulox Dry (calved 4 months after treatment)
C15 Depocillin and 
Nafpenzal
Unknown
C16 Depocillin and 
Nafpenzal
Mid lactation (calved 5 months after 
treatment)
D1 Synulox Dry (calved 1 month after treatment)
D2 Depocillin and 
Nafpenzal
Mid lactation (calved 4 months after 
treatment)
D3 Depocillin and 
Nafpenzal
Unknown
D4 Depocillin and 
Nafpenzal
Early lactation (calved 2 months)
D5 Depocillin and 
Nafpenzal
Late lactation (calved 7 months)
D8 Depocillin and 
Nafpenzal
Late lactation (calved 7 months)
DIO Synulox Dry (calved 1 month after treatment)
D12 Depocillin and 
Nafpenzal
Early lactation (calved 2 months)
D14 Depocillin and 
Nafpenzal
Early lactation (calved 2 months)
D15 Depocillin and 
Nafpenzal
Early lactation (calved 2 weeks)
D16 Synulox (1 day) then 
Depocillin and 
Nafpenzal
Calved on the 3rd day of treatment
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Cow ID Treatment
administered
Category
E3 Depocillin and 
Nafpenzal
Unknown
E4 Depocillin and 
Nafpenzal
Early lactation (calved 1 week)
E5 Depocillin and 
Nafpenzal
Unknown
E6 Depocillin and 
Nafpenzal
Early lactation (calved 1 week)
E7 Depocillin and 
Nafpenzal
Unknown
E8 Depocillin and 
Nafpenzal
Unknown
E9 Depocillin and 
Nafpenzal
Unknown
Unknown - denotes that records were not available to enable the stage o f gestation to 
be calculated, but that the cow was lactating.
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Appendix 7
Bacteriology results for all the cows in the herd, 
highlighting those cows and quarters from which 
Staphylococcus aureus was isolated
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Appendix 8
Details of the milk sales for the last three quota years
Ik Ltd. Welcome to DairyTrend 14/09/98
   Yearly Enqui ry  — ---------------------------------
ode. Name:
t r e ) Bfat Prot Lact TBC SCC Val ue TBC Amt SCC Amt
.463 3. 76 3 07 4 55 10 574 2 813. 31 24 93 -24 .93
.315 3 38 3 22 4 66 7 502 3 863. 57 34 63 -34 .63
.869 3 72 3 44 4 67 7 401 3 870. 79 33 74 -33 .74
,441 3 68 3 52 4 62 7 362 3 392. 43 28 88
.620 3 85 3 35 4 65 7 350 2 741. 35 23 24
.286 3 94 3 57 4 64 7 323 3 268. 22 26 57
.051 4 39 3 45 4 65 6 298 3 089 95 24 10
.644 4 27 3 11 4 72 6 326 3 200 38 25 29
.359 4 21 3 03 4 76 7 368 3 813 07 30 72
.774 4 11 2 95 4 70 7 402 3 283 68 27 55 -55 .10
.396 4 13 3 05 4 76 9 437 3 499 69 28 79 -57 .58
.371 4 03 3 10 4 76 10 487 3 .487 94 28 74 -57 .48
t o  Sc reen P e r io d Year t o  Date ( 1995 )
8 5 ,9 9 4 Supply 168 .589
3. 70 TBC Avg: 8 B fa t  Avg 3 . 9 4  TBC Avg: 8
3.:36 SCC Avg: 419 P ro t  Avg 3 . 2 4  SCC Avg: 403
t  Haulage  Average Next Prev  Next-Y r  P rev -Y r  D e t a i l  E x i t
.Sco t t i sh  Milk Ltd. Welcome to  DairyTrend
Yearly Enquiry ----------
14/09/98
Farm Code.
4.
Name.
Nth Vol (Litre) Bfat Prot Lact TBC SCC Value TBC Amt SCC Amt
|Apr 13,440 4.05 3.02  4.69 10 558 3.008.39 26.88 -134.40
May 17,000 3.82 3.19  4.69 10 590 3,488 .84 34.00 -170.00
| Jun 16.059 3.65 3.40 4.79 12 576 3,176.45 -160.59
jjiil 15,281 3.72 3.41 4.68 12 536 4.003.19 30.56 -152.81
Aug 10.783 3.75 3.36  4.55 10 530 2,713.13 21.57 -107.83
|Sep 10.832 3.96 3.64  4.56 13 522 2,909.85 21.66 -108.32
Oct 9.683 4.28 3.49  4.54 16 609 2,549.82 -96 .83
|Nov 10,247 4.13 3.27 4.60 16 613 2.514.10 -102.47
|Dec 10,295 3.95 3.12 4.61 15 672 2,260.14 -102.95
Jan 11,091 3.94 3.07 4.66 15 658 2,186.93 -332.73
Feb 10.494 3.94 3.02  4.72 10 595 2.068.22 20.99 -314.82
|Mar 9.048 3.98 2.90 4.70 9 502 1.701.50 18.10 -271.44
Year t o  Screen Period Year to  Date ( 1996 )
Supply: 83,395 Supply 144.253
Bfat Avg: 3.82 TBC Avg: 11 Bfat  Avg 3.91 TBC Avg: 12
Prot Avg: 3.32 SCC Avg: 552 Prot  Avg 3.25  SCC Avg: 580
133
Units S t a t  Haulage Average Next Prev Next-Yr Prev-Yr Detai l  Exit
S c o t t i s h  Milk Ltd. Welcome t o  DairyTrend
Yearly  Enquiry ----------
14/09/98
Farm Code: Name:
Mth Vol (L itre ) Bfat Prot Lact TBC SCC Val ue TBC Amt SCC Amt
Apr 13,209 3. 90 2 90 4 76 7 365 2 532. 19 39 63
May 19,141 3. 73 3 20 4 71 6 281 3 338. 14 57 42
Jun 18,764 3. 81 3 42 4 90 4 245 3 484. 40 56 29 18 76
Jul 15,402 3. 84 3 47 4 88 4 242 3 543. 87 46 21 15 40
Aug 14,630 3. 84 3 42 4 87 7 232 3 530. 27 43 89 14 63
Sep 12,525 4. 00 3 60 4 77 6 209 3 153. 89 37 58 12 53
Oct 10,015 4. 50 3 64 4 77 5 162 2 431. 61 30 05 10 02
Nov 10,356 4. 38 3 34 4 72 7 155 2 328. 06 31 07 10 36
Dec 12,564 4. 08 3 05 4 85 6 156 2 432. 41 37 69 12 56
Jan 11,376 3. 72 2 88 4 65 5 184 2 051. 06 34 13 11 38
Feb 11,370 3. 71 2 85 4 80 8 250 2 036 30 34 11 11 37
Mar 12,593 3. 76 2 86 4 82 5 323 2 196 29 37 78
Year to  Screen Peri od | Year to Date ( 1997 )
Supply 93 ,671 Supply 161. 945
134
Bfat Avg: 
Prot Avg:
3.84  TBC Avg 
3.33  SCC Avg
6 Bfat  Avg 
262 Prot  Avg
3.91  TBC Avg: 6
3 .23  SCC Avg: 234
Units  S t a t  Haulage Average Next Prev Next-Yr Prev-Yr D eta i l  Ex i t
. S co t t i s h  Mi Ik Ltd 
+-*_--------------------------
Farm Code:
Welcome to  DairyTrend
Yearly Enquiry ----------
Name:
14/09/98
,135
|Mth Vol (Litre)  Bfat Prot Lact TBC SCC Value TBC Amt SCC Amt
| Apr 12,152 3.70  2.84  4 81 6 352 1.851 .98 36.46 -60 .76
I May 16.053 3.64 2.89  4 77 7 326 2.133 .38 48.16
| Jun 17.115 3.70 3 .35 4 93 7 318 2.555 .26 51.35
Jul 16,220 3.94 3.43 4 90 18 338 3 ,381.96
1 Aug 13.685 4.33 3.40 4 81 11 377 2.872.54 -68 .43
|Sep 4,032 3.86  3.41 4 80 6 371 0.00 12.10 -20 .16
j Oct 0.00
Nov 0.00
j Dec 0.00
| Jan 0.00
| Feb 0.00
| Ma r 0.00
Year to  Screen Per iod | Year t o  Date ( 1998 )
Supply 79,257 Supply 79.257
Bfat Avg 3.85 TBC Avg: 9 Bfat  Avg 3.85  TBC Avg : 9
Prot Avg 3.21 SCC Avg: 347 Prot Avg 3.21  SCC Avg : 347
Units S ta t  Haulage Aver.Ale Next Prev Next-Yr Prev -Yr D eta i l Ex i t
S e l e c t  d i sp la y  u n i t s
----------------------------------- Farm Fleader Enquiry ----------------------------------------------+
Farm Code: Year: 1995 Base Bfat: 3.840 Adj. Bfat: 3.850000 I
_________________________________________   , _+ 136
Milk Supply B u t t e r - P r o f i l e Quota B u t t e r f a t Adjus ted
Mth L i t r e s f a t D e ta i I s L i t r e s Adjustment Supply
Apr 12.463 3.760 8.2191 15,067 202- 12,261
May 17.315 3.380 8.4932 15.569 1,465- 15,850
Jun 16.869 3.720 8.2191 15,067 395- 16,475
Jul 14,441 3.680 8.4932 15.569 442- 13,999
Aug 11.620 3.850 8.4932 15,569 0 11,620
Sep 13.286 3.940 8.2191 15.067 215 13.501
Oct 12.051 4.390 8.4932 15,569 1,171 13,223
Nov 12.644 4.270 8.2191 15,067 956 13.600
Dec 15.359 4.210 8.4932 15.569 995 16.354
Jan 13,774 4.110 8.4932 15.569 645 14,418
Feb * 13.917 4.130 7.6712 14,062 701 14,619
Mar 14.371 4.030 8.4932 15.569 466 14,837
YTD. 168,112 3.940 100.0000 183,311 2,723 170,835
YTD Var (-8.29%) 15,199- (-6.85%) 12.553-
Annual 168.112 3.940 183,311
Ann Var (-8.29%) 15.199- (-6.85%) 12,476-
irm: Leap Adj . : 479
Next Prev Next -Yr Prev--yr Q ua l i ty Exi t
Display prev ious  year
-----------------------------------------  Parm  Header Enquiry ---------------------------------------------- +
Farm Code: Year: 1996 Base B fa t :  3.840 Adj. B fa t :  3.850000 I
________________________________________________________________________  )  137
Milk Supply B u t t e r - P r o f i l e Quota B u t t e r f a t A djus ted
Mth L i t r e s f a t D e ta i I s L i t r e s  Adjustment Supply
Apr 13,440 4.050 7.3926 13,551 484 13,924
May 17.000 3.820 10.2706 18.827 92- 16.908
Jun 16.059 3.650 10.0061 18,342 578- 15,481
Jul 15.281 3.720 8.5659 15.702 358- 14.924
Aug 10,783 3.750 6.8926 12,635 194- 10,589
Sep 10.832 3.960 7.8806 14.446 214 11,047
Oct 9.683 4.280 7.1482 13.103 749 10.432
Nov 10.247 4.130 7.4996 13.748 516 10.764
Dec 10.295 3.950 9.1103 16,700 185 10.480
Jan 11.091 3.940 8.1699 14.976 180 11,270
Feb 10.494 3.940 8.5391 15.653 170 10.664
Mar 9,048 3.980 8.5245 15,626 212 9.260
YTD. 144.252 3.910 100.0000 183,311 1,558 145,810
YTD Var ( - 2 1 . 31°o) 39,059- ( -20.4920 37.570-
Annual 144,252 3.910 183,311
Ann Var ( -21 .311) 39 .059- (-20.49%) 37.501-
Farm:
Next Prev Next-Yr P rev -y r  Q u a l i ty  E x i t
Display p rev ious  yea r
+-------    Farm Header Enquiry --------------------------------------------- +
| ' Farm Code: Year: 1997 Base Bfa t :  3.840 Adj. Bfat :  3.856242 |
______________________________________________________________________ .-____+ 138
Milk Supply Bu t te r - P r o f i l e Quota B u t t e r f a t Adjusted
Mth L i t r e s f a t D e ta i I s L i t r e s  Adjustment Supply
Apr 13.209 3.900 9.3169 15,216 95 13,304
May 19,141 3.730 11.7846 19,246 448- 18,693
Jun 18,764 3.810 11.1325 18,181 169- 18,595
Jul 15,402 3.840 10.5933 17,300 55- 15,346
Aug 14,630 3.840 7.4748 12,207 53- 14,578
Sep 12,525 4.000 7.5092 12,263 316 12,841
Oct 10,015 4.500 6.7125 10,962 1,154 11,169
Nov 10,356 4.380 7.1038 11,601 969 11,325
Dec 12,564 4.080 7.1367 11,655 498 13,062
Jan 11,376 3.720 7.6882 12,556 287- 11,089
Feb 11.370 3.710 7.2746 11,880 307- 11,063
Mar 12.593 3.760 6.2729 10.244 227- 12,367
YTD. 161,944 3.910 100.0000 163,311 1,457 163,402
YTD Var (-0.84%) 1,367- (0.07%) 119
Annual 161,944 3.910 163,311
Ann Var (-0.84%) 1.367- (0.07%) 91
Far m:
Next Prev Next-Yr Prev-yr Q ual i ty  Exit
Display prev ious  year
--------------------------------------- parm Header Enquiry --------------------------------------------
Farm Code: Year: 1998 Base Bfa t :  3.840 Adj. Bfat :  3.856242
Milk Supply B u t te r - P r o f i l e Quota B u t t e r f a t Adjusted
Mth L i t r e s f a t D e ta i I s L i t r e s  Adjustment Supply
Apr 12.152 3 .700 8.1565 14.952 350- 11,802
May 16.053 3 .640 11.8193 21.666 636- 15,417
Jun 17,115 3 .700 11.5864 21,239 493- 16,622
Jul 16,220 3 .940 9.5105 17,434 234 16,454
Aug 13,685 4 .330 9.0341 • 16,561 1,158 14,843
Sep 4,032 3 .860 7.7343 14,178 0 4,032
Oct 0 0 .000 6.1841 11,336 0 0
Nov 0 0 .000 6.3948 11,722 0 0
Dec 0 0 .000 7.7583 14,222 0 0
Jan 0 0 .000 7.0245 12,877 0 0
Feb 0 0 .000 7.0207 12,870 0 0
Mar 0 0 .000 7.7765 14,255 0 0
YTD. 79,257 3 .850 100.0000 96,105 143- 79,114
YTD Var (-17.53%) 1 6 . BAS­ (-17.62%) 16.935-
Annual 0 3 .850 ISS, 311
Ann Var (-56.76%) 104,054- (-56.81%) 104,197-
Farm:
Next Prev Next-Yr Prev-yr  Q ua l i ty  Exi t
Display next  record
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